{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T16:17:21Z","timestamp":1790612241090,"version":"4.1.0"},"reference-count":255,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,21]],"date-time":"2025-05-21T00:00:00Z","timestamp":1747785600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,21]],"date-time":"2025-05-21T00:00:00Z","timestamp":1747785600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lipids Health Dis"],"DOI":"10.1186\/s12944-025-02605-7","type":"journal-article","created":{"date-parts":[[2025,5,21]],"date-time":"2025-05-21T03:30:45Z","timestamp":1747798245000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Long noncoding RNAs in familial hypercholesterolemia: biomarkers, therapeutics, and AI in precision medicine"],"prefix":"10.1186","volume":"24","author":[{"given":"Hussam","family":"Daghistani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gehan A.","family":"Hegazy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manal","family":"Alkhalofah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Afaf","family":"Alsobeihy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Nasser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hoda","family":"Gad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taghreed","family":"Shamrani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed","family":"Mufrrih","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dareen","family":"Alyousfi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,21]]},"reference":[{"key":"2605_CR1","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1159\/000051159","volume":"4","author":"SW Fouchier","year":"2001","unstructured":"Fouchier SW, Defesche JC, Kastelein JJP. Global Perspectives of Familial Hypercholesterolemia. Public Health Genomics. 2001;4:61\u20137.","journal-title":"Public Health Genomics"},{"key":"2605_CR2","doi-asserted-by":"publisher","first-page":"993","DOI":"10.5114\/aoms.2019.86972","volume":"16","author":"VA Pallazola","year":"2020","unstructured":"Pallazola VA, Sathiyakumar V, Park J, Vakil RM, Toth P, Lazo-Elizondo M, et al. Modern prevalence of dysbetalipoproteinemia (Fredrickson-Levy-Lees type III hyperlipoproteinemia). Arch Med Sci. 2020;16:993\u20131003.","journal-title":"Arch Med Sci"},{"key":"2605_CR3","doi-asserted-by":"crossref","unstructured":"Pirillo A, Catapano AL. Familial Hypercholesterolemia. Encycl Cardiovasc Res Med [Internet]. Elsevier; 2018 [cited 2025 Apr 8]. p. 285\u201397. Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/B978012809657499567X","DOI":"10.1016\/B978-0-12-809657-4.99567-X"},{"key":"2605_CR4","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.atherosclerosis.2013.08.035","volume":"231","author":"J Stock","year":"2013","unstructured":"Stock J, New EAS. Consensus Statement on FH: Improving the care of FH patients. Atherosclerosis. 2013;231:69\u201371.","journal-title":"Atherosclerosis"},{"key":"2605_CR5","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1016\/j.jacc.2019.05.043","volume":"74","author":"M Trinder","year":"2019","unstructured":"Trinder M, Li X, DeCastro ML, Cermakova L, Sadananda S, Jackson LM, et al. Risk of Premature Atherosclerotic Disease in Patients With Monogenic Versus Polygenic Familial Hypercholesterolemia. J Am Coll Cardiol. 2019;74:512\u201322.","journal-title":"J Am Coll Cardiol"},{"key":"2605_CR6","doi-asserted-by":"publisher","unstructured":"Desgagn\u00e9 V, Bouchard L, Gu\u00e9rin R. microRNAs in lipoprotein and lipid metabolism: from biological function to clinical application. Clin Chem Lab Med CCLM [Internet]. 2017 [cited 2025 Mar 5];55. Available from: https:\/\/www.degruyter.com\/document\/doi\/https:\/\/doi.org\/10.1515\/cclm-2016-0575\/html","DOI":"10.1515\/cclm-2016-0575\/html"},{"key":"2605_CR7","doi-asserted-by":"publisher","first-page":"8337","DOI":"10.3390\/ijms21218337","volume":"21","author":"K-H Lee","year":"2020","unstructured":"Lee K-H, Hwang H-J, Cho J-Y. Long Non-Coding RNA Associated with Cholesterol Homeostasis and Its Involvement in Metabolic Diseases. Int J Mol Sci. 2020;21:8337.","journal-title":"Int J Mol Sci"},{"key":"2605_CR8","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s12944-019-0977-8","volume":"18","author":"A Pakiet","year":"2019","unstructured":"Pakiet A, Kobiela J, Stepnowski P, Sledzinski T, Mika A. Changes in lipids composition and metabolism in colorectal cancer: a review. Lipids Health Dis. 2019;18:29.","journal-title":"Lipids Health Dis"},{"key":"2605_CR9","doi-asserted-by":"crossref","unstructured":"Sun X, Feinberg MW. MicroRNA Regulation of HDL Homeostasis. HDL Handb [Internet]. Elsevier; 2017 [cited 2025 Mar 5]. p. 209\u201329. Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/B9780128125137000100","DOI":"10.1016\/B978-0-12-812513-7.00010-0"},{"key":"2605_CR10","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/1480-9222-16-11","volume":"16","author":"J Cao","year":"2014","unstructured":"Cao J. The functional role of long non-coding RNAs and epigenetics. Biol Proced Online. 2014;16:42.","journal-title":"Biol Proced Online"},{"key":"2605_CR11","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1080\/15476286.2015.1063770","volume":"12","author":"P Han","year":"2015","unstructured":"Han P, Chang C-P. Long non-coding RNA and chromatin remodeling. RNA Biol. 2015;12:1094\u20138.","journal-title":"RNA Biol"},{"key":"2605_CR12","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1007\/s12016-017-8611-x","volume":"54","author":"AA Momtazi","year":"2018","unstructured":"Momtazi AA, Banach M, Pirro M, Stein EA, Sahebkar A. MicroRNAs: New Therapeutic Targets for Familial Hypercholesterolemia? Clin Rev Allergy Immunol. 2018;54:224\u201333.","journal-title":"Clin Rev Allergy Immunol"},{"key":"2605_CR13","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1042\/BCJ20180440","volume":"476","author":"EJ Shields","year":"2019","unstructured":"Shields EJ, Petracovici AF, Bonasio R. lncRedibly versatile: biochemical and biological functions of long noncoding RNAs. Biochem J. 2019;476:1083\u2013104.","journal-title":"Biochem J"},{"key":"2605_CR14","doi-asserted-by":"crossref","unstructured":"Wang XQ, Dostie J. Reciprocal regulation of chromatin state and architecture by HOTAIRM1 contributes to temporal collinear HOXA gene activation. Nucleic Acids Res. 2017;45(3):1091\u2013104.","DOI":"10.1093\/nar\/gkw966"},{"key":"2605_CR15","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1097\/HCO.0000000000000454","volume":"32","author":"S Haemmig","year":"2017","unstructured":"Haemmig S, Simion V, Yang D, Deng Y, Feinberg MW. Long noncoding RNAs in cardiovascular disease, diagnosis, and therapy. Curr Opin Cardiol. 2017;32:776\u201383.","journal-title":"Curr Opin Cardiol"},{"key":"2605_CR16","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1016\/j.bbadis.2017.02.024","volume":"1863","author":"D Han","year":"2017","unstructured":"Han D, Gao Q, Cao F. Long noncoding RNAs (LncRNAs) \u2014 The dawning of a new treatment for cardiac hypertrophy and heart failure. Biochim Biophys Acta BBA - Mol Basis Dis. 2017;1863:2078\u201384.","journal-title":"Biochim Biophys Acta BBA - Mol Basis Dis"},{"key":"2605_CR17","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.vph.2018.01.003","volume":"114","author":"V Simion","year":"2019","unstructured":"Simion V, Haemmig S, Feinberg MW. LncRNAs in vascular biology and disease. Vascul Pharmacol. 2019;114:145\u201356.","journal-title":"Vascul Pharmacol"},{"key":"2605_CR18","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2021.688546","volume":"8","author":"W-C Ye","year":"2021","unstructured":"Ye W-C, Huang S-F, Hou L-J, Long H-J, Yin K, Hu CY, et al. Potential Therapeutic Targeting of lncRNAs in Cholesterol Homeostasis. Front Cardiovasc Med. 2021;8: 688546.","journal-title":"Front Cardiovasc Med"},{"key":"2605_CR19","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.bcp.2013.03.021","volume":"86","author":"A Mazein","year":"2013","unstructured":"Mazein A, Watterson S, Hsieh W-Y, Griffiths WJ, Ghazal P. A comprehensive machine-readable view of the mammalian cholesterol biosynthesis pathway. Biochem Pharmacol. 2013;86:56\u201366.","journal-title":"Biochem Pharmacol"},{"key":"2605_CR20","doi-asserted-by":"publisher","first-page":"3426","DOI":"10.3390\/ijms19113426","volume":"19","author":"A Benito-Vicente","year":"2018","unstructured":"Benito-Vicente A, Uribe KB, Jebari S, Galicia-Garcia U, Ostolaza H, Martin C. Familial Hypercholesterolemia: The Most Frequent Cholesterol Metabolism Disorder Caused Disease. Int J Mol Sci. 2018;19:3426.","journal-title":"Int J Mol Sci"},{"key":"2605_CR21","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/j.tem.2010.08.008","volume":"21","author":"KJ Moore","year":"2010","unstructured":"Moore KJ, Rayner KJ, Su\u00e1rez Y, Fern\u00e1ndez-Hernando C. microRNAs and cholesterol metabolism. Trends Endocrinol Metab. 2010;21:699\u2013706.","journal-title":"Trends Endocrinol Metab"},{"key":"2605_CR22","doi-asserted-by":"publisher","unstructured":"Popj\u00e1k G, Cornforth JW. The Biosynthesis of Cholesterol. In: Nord FF, editor. Adv Enzymol - Relat Areas Mol Biol [Internet]. 1st ed. Wiley; 1960 [cited 2025 Mar 5]. p. 281\u2013335. Available from: https:\/\/onlinelibrary.wiley.com\/doi\/https:\/\/doi.org\/10.1002\/9780470122679.ch7","DOI":"10.1002\/9780470122679.ch7"},{"key":"2605_CR23","doi-asserted-by":"publisher","unstructured":"Price NL, Fern\u00e1ndez-Hernando C. Noncoding RNAs in Cholesterol Metabolism and Atherosclerosis. In: Thum T, Dimmeler S, editors. Non-Coding RNAs Vasc [Internet]. Cham: Springer International Publishing; 2017 [cited 2025 Mar 5]. p. 21\u201337. Available from: https:\/\/link.springer.com\/https:\/\/doi.org\/10.1007\/978-3-319-52945-5_2","DOI":"10.1007\/978-3-319-52945-5_2"},{"key":"2605_CR24","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.cca.2019.09.022","volume":"500","author":"H Yang","year":"2020","unstructured":"Yang H, Zhang M, Long S, Tuo Q, Tian Y, Chen J, et al. Cholesterol in LDL receptor recycling and degradation. Clin Chim Acta. 2020;500:81\u20136.","journal-title":"Clin Chim Acta"},{"key":"2605_CR25","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1038\/nature17674","volume":"534","author":"T Sallam","year":"2016","unstructured":"Sallam T, Jones MC, Gilliland T, Zhang L, Wu X, Eskin A, et al. Feedback modulation of cholesterol metabolism by the lipid-responsive non-coding RNA LeXis. Nature. 2016;534:124\u20138.","journal-title":"Nature"},{"key":"2605_CR26","doi-asserted-by":"publisher","unstructured":"Sallam T, Jones M, Gilliland T, Li Z, Wu X, Eskin A, et al. Abstract 13674: Feedback Regulation of Cholesterol Metabolism by Lexis, a Lipid-responsive Non-coding RNA. Circulation [Internet]. 2015 [cited 2025 Mar 5];132. Available from: https:\/\/www.ahajournals.org\/doi\/https:\/\/doi.org\/10.1161\/circ.132.suppl_3.13674","DOI":"10.1161\/circ.132.suppl_3.13674"},{"key":"2605_CR27","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1038\/s42255-018-0012-9","volume":"1","author":"T Sallam","year":"2018","unstructured":"Sallam T, Tontonoz P. Lnc-ing microRNA activity to atheroprotection. Nat Metab. 2018;1:10\u20131.","journal-title":"Nat Metab"},{"key":"2605_CR28","doi-asserted-by":"publisher","unstructured":"Juvet LK, Nebb HI. Liver X Receptors (LXRs) \u2013 Important Regulators of Lipid Homeostasis. In: Duttaroy AK, Spener F, editors. Cell Proteins Their Fat Acids Health Dis [Internet]. 1st ed. Wiley; 2003 [cited 2025 Mar 5]. p. 209\u201323. Available from: https:\/\/onlinelibrary.wiley.com\/doi\/https:\/\/doi.org\/10.1002\/3527601546.ch11","DOI":"10.1002\/3527601546.ch11"},{"key":"2605_CR29","doi-asserted-by":"publisher","first-page":"3081","DOI":"10.3748\/wjg.v10.i21.3081","volume":"10","author":"LW Weber","year":"2004","unstructured":"Weber LW. Maintaining cholesterol homeostasis: Sterol regulatory element-binding proteins. World J Gastroenterol. 2004;10:3081.","journal-title":"World J Gastroenterol"},{"key":"2605_CR30","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1161\/CIRCULATIONAHA.117.029002","volume":"136","author":"P Tontonoz","year":"2017","unstructured":"Tontonoz P, Wu X, Jones M, Zhang Z, Salisbury D, Sallam T. Long Noncoding RNA Facilitated Gene Therapy Reduces Atherosclerosis in a Murine Model of Familial Hypercholesterolemia. Circulation. 2017;136:776\u20138.","journal-title":"Circulation"},{"key":"2605_CR31","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.ddstr.2005.05.018","volume":"2","author":"MN Bradley","year":"2005","unstructured":"Bradley MN, Tontonoz P. LXR: A nuclear receptor target for cardiovascular disease? Drug Discov Today Ther Strateg. 2005;2:97\u2013103.","journal-title":"Drug Discov Today Ther Strateg"},{"key":"2605_CR32","doi-asserted-by":"publisher","DOI":"10.1111\/eci.14083","volume":"54","author":"R Scicali","year":"2024","unstructured":"Scicali R, Bosco G, Scamporrino A, Di Mauro S, Filippello A, Di Giacomo BF, et al. Evaluation of high-density lipoprotein-bound long non-coding RNAs in subjects with familial hypercholesterolaemia. Eur J Clin Invest. 2024;54: e14083.","journal-title":"Eur J Clin Invest"},{"key":"2605_CR33","doi-asserted-by":"publisher","first-page":"257","DOI":"10.3109\/09687688.2012.729094","volume":"29","author":"A Ferrari","year":"2012","unstructured":"Ferrari A, Fiorino E, Giudici M, Gilardi F, Galmozzi A, Mitro N, et al. Linking epigenetics to lipid metabolism: Focus on histone deacetylases. Mol Membr Biol. 2012;29:257\u201366.","journal-title":"Mol Membr Biol"},{"key":"2605_CR34","doi-asserted-by":"publisher","unstructured":"Xiao Y, Xu J, Yin W. Aberrant Epigenetic Modifications of Non-coding RNAs in Human Disease. In: Li X, Xu J, Xiao Y, Ning S, Zhang Y, editors. Non-Coding RNAs Complex Dis [Internet]. Singapore: Springer Singapore; 2018 [cited 2025 Mar 5]. p. 65\u201375. Available from: http:\/\/link.springer.com\/https:\/\/doi.org\/10.1007\/978-981-13-0719-5_7","DOI":"10.1007\/978-981-13-0719-5_7"},{"key":"2605_CR35","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/S0022-2275(20)30180-2","volume":"43","author":"PA Edwards","year":"2002","unstructured":"Edwards PA, Kast HR, Anisfeld AM. BAREing it all: the adoption of LXR and FXR and their roles in lipid homeostasis. J Lipid Res. 2002;43:2\u201312.","journal-title":"J Lipid Res"},{"key":"2605_CR36","doi-asserted-by":"publisher","first-page":"2819","DOI":"10.1101\/gad.844900","volume":"14","author":"JJ Repa","year":"2000","unstructured":"Repa JJ, Liang G, Ou J, Bashmakov Y, Lobaccaro J-MA, Shimomura I, et al. Regulation of mouse sterol regulatory element-binding protein-1c gene (SREBP-1c) by oxysterol receptors. LXR\u03b1 and LXR\u03b2 Genes Dev. 2000;14:2819\u201330.","journal-title":"LXR\u03b1 and LXR\u03b2. Genes Dev."},{"key":"2605_CR37","doi-asserted-by":"publisher","first-page":"4558867","DOI":"10.1155\/2022\/4558867","volume":"2022","author":"KC Das","year":"2022","unstructured":"Das KC, Hossain MU, Moniruzzaman M, Salimullah M, Akhteruzzaman S. High\u2010Risk Polymorphisms Associated with the Molecular Function of Human HMGCR Gene Infer the Inhibition of Cholesterol Biosynthesis. Wang B, editor. BioMed Res Int. 2022;2022:4558867.","journal-title":"BioMed Res Int."},{"key":"2605_CR38","doi-asserted-by":"publisher","first-page":"665","DOI":"10.5551\/jat.43372","volume":"25","author":"L Jiang","year":"2018","unstructured":"Jiang L, Wang L-Y, Cheng X. Novel Approaches for the Treatment of Familial Hypercholesterolemia: Current Status and Future Challenges. J Atheroscler Thromb. 2018;25:665\u201373.","journal-title":"J Atheroscler Thromb"},{"key":"2605_CR39","doi-asserted-by":"publisher","first-page":"S154","DOI":"10.3177\/jnsv.61.S154","volume":"61","author":"LJ Sharpe","year":"2015","unstructured":"Sharpe LJ, Howe V, Prabhu AV, Luu W, Brown AJ. Navigating the Shallows and Rapids of Cholesterol Synthesis Downstream of HMGCR. J Nutr Sci Vitaminol (Tokyo). 2015;61:S154\u20136.","journal-title":"J Nutr Sci Vitaminol (Tokyo)"},{"key":"2605_CR40","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1038\/aps.2016.158","volume":"38","author":"M Liu","year":"2017","unstructured":"Liu M, Gao M, Li C, Yu C, Yan H, Peng C, et al. Dicer1\/miR-29\/HMGCR axis contributes to hepatic free cholesterol accumulation in mouse non-alcoholic steatohepatitis. Acta Pharmacol Sin. 2017;38:660\u201371.","journal-title":"Acta Pharmacol Sin"},{"key":"2605_CR41","doi-asserted-by":"publisher","first-page":"2334","DOI":"10.3390\/biomedicines10102334","volume":"10","author":"O Sweef","year":"2022","unstructured":"Sweef O, Yang C, Wang Z. The Oncogenic and Tumor Suppressive Long Non-Coding RNA\u2013microRNA\u2013Messenger RNA Regulatory Axes Identified by Analyzing Multiple Platform Omics Data from Cr(VI)-Transformed Cells and Their Implications in Lung Cancer. Biomedicines. 2022;10:2334.","journal-title":"Biomedicines"},{"key":"2605_CR42","doi-asserted-by":"publisher","first-page":"2879","DOI":"10.7150\/ijbs.84994","volume":"19","author":"W Chen","year":"2023","unstructured":"Chen W, Xu J, Wu Y, Liang B, Yan M, Sun C, et al. The potential role and mechanism of circRNA\/miRNA axis in cholesterol synthesis. Int J Biol Sci. 2023;19:2879\u201396.","journal-title":"Int J Biol Sci"},{"key":"2605_CR43","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.lfs.2018.04.028","volume":"203","author":"J Huang","year":"2018","unstructured":"Huang J, Chen S, Cai D, Bian D, Wang F. Long noncoding RNA lncARSR promotes hepatic cholesterol biosynthesis via modulating Akt\/SREBP-2\/HMGCR pathway. Life Sci. 2018;203:48\u201353.","journal-title":"Life Sci"},{"key":"2605_CR44","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.bbrc.2018.03.127","volume":"499","author":"M Zhang","year":"2018","unstructured":"Zhang M, Chi X, Qu N, Wang C. Long noncoding RNA lncARSR promotes hepatic lipogenesis via Akt\/SREBP-1c pathway and contributes to the pathogenesis of nonalcoholic steatohepatitis. Biochem Biophys Res Commun. 2018;499:66\u201370.","journal-title":"Biochem Biophys Res Commun"},{"key":"2605_CR45","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1007\/BF01716251","volume":"62","author":"JM Dietschy","year":"1984","unstructured":"Dietschy JM. Regulation of cholesterol metabolism in man and in other species. Klin Wochenschr. 1984;62:338\u201345.","journal-title":"Klin Wochenschr"},{"key":"2605_CR46","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1242\/jcs.1985.Supplement_3.13","volume":"1985","author":"JL Goldstein","year":"1985","unstructured":"Goldstein JL, Brown MS. The ldl receptor and the regulation of cellular cholesterol metabolism. J Cell Sci. 1985;1985:131\u20137.","journal-title":"J Cell Sci"},{"key":"2605_CR47","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1126\/science.1168974","volume":"325","author":"N Zelcer","year":"2009","unstructured":"Zelcer N, Hong C, Boyadjian R, Tontonoz P. LXR Regulates Cholesterol Uptake Through Idol-Dependent Ubiquitination of the LDL Receptor. Science. 2009;325:100\u20134.","journal-title":"Science"},{"key":"2605_CR48","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1089\/dna.2016.3422","volume":"35","author":"C Huang","year":"2016","unstructured":"Huang C, Hu Y-W, Zhao J-J, Ma X, Zhang Y, Guo F-X, et al. Long Noncoding RNA HOXC-AS1 Suppresses Ox-LDL-Induced Cholesterol Accumulation Through Promoting HOXC6 Expression in THP-1 Macrophages. DNA Cell Biol. 2016;35:722\u20139.","journal-title":"DNA Cell Biol"},{"key":"2605_CR49","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.omtn.2019.05.024","volume":"17","author":"RM Ray","year":"2019","unstructured":"Ray RM, Hansen AH, Slott S, Taskova M, Astakhova K, Morris KV. Control of LDL Uptake in Human Cells by Targeting the LDLR Regulatory Long Non-coding RNA BM450697. Mol Ther - Nucleic Acids. 2019;17:264\u201376.","journal-title":"Mol Ther - Nucleic Acids"},{"key":"2605_CR50","doi-asserted-by":"publisher","first-page":"3651","DOI":"10.2147\/DDDT.S249830","volume":"14","author":"K Chi","year":"2020","unstructured":"Chi K, Zhang J, Sun H, Liu Y, Li Y, Yuan T, et al. Knockdown of lncRNA HOXA-AS3 Suppresses the Progression of Atherosclerosis via Sponging miR-455-5p. Drug Des Devel Ther. 2020;14:3651\u201362.","journal-title":"Drug Des Devel Ther"},{"key":"2605_CR51","first-page":"22","volume":"9","author":"MA Omarov","year":"2024","unstructured":"Omarov MA, Mulyukov AR, Khalitov RV, Safarov SI, Ayupova GU, Demianenko ON, et al. Epigenetic modulation in medicine: Regulation of gene expression in the context of pathogenesis and therapy. Acta Biomed Sci. 2024;9:22\u201333.","journal-title":"Acta Biomed Sci"},{"key":"2605_CR52","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/s10020-023-00685-8","volume":"29","author":"Z Han","year":"2023","unstructured":"Han Z, Hu H, Yin M, Lin Y, Yan Y, Han P, et al. HOXA1 participates in VSMC-to-macrophage-like cell transformation via regulation of NF-\u03baB p65 and KLF4: a potential mechanism of atherosclerosis pathogenesis. Mol Med. 2023;29:104.","journal-title":"Mol Med"},{"key":"2605_CR53","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1161\/ATVBAHA.108.178319","volume":"29","author":"PD N\u2019Guessan","year":"2009","unstructured":"N\u2019Guessan PD, Riediger F, Vardarova K, Scharf S, Eitel J, Opitz B, et al. Statins Control Oxidized LDL-Mediated Histone Modifications and Gene Expression in Cultured Human Endothelial Cells. Arterioscler Thromb Vasc Biol. 2009;29:380\u20136.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2605_CR54","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1194\/jlr.M500526-JLR200","volume":"47","author":"RJ Schmidt","year":"2006","unstructured":"Schmidt RJ, Ficorilli JV, Zhang Y, Bramlett KS, Beyer TP, Borchert K, et al. A 15-ketosterol is a liver X receptor ligand that suppresses sterol-responsive element binding protein-2 activity. J Lipid Res. 2006;47:1037\u201344.","journal-title":"J Lipid Res"},{"key":"2605_CR55","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.1016\/j.biochi.2011.07.004","volume":"93","author":"SM Colley","year":"2011","unstructured":"Colley SM, Leedman PJ. Steroid Receptor RNA Activator \u2013 A nuclear receptor coregulator with multiple partners: Insights and challenges. Biochimie. 2011;93:1966\u201372.","journal-title":"Biochimie"},{"key":"2605_CR56","doi-asserted-by":"publisher","first-page":"8066","DOI":"10.1038\/s41598-017-08559-w","volume":"7","author":"R Fornes","year":"2017","unstructured":"Fornes R, Maliqueo M, Hu M, Hadi L, Jimenez-Andrade JM, Ebefors K, et al. The effect of androgen excess on maternal metabolism, placental function and fetal growth in obese dams. Sci Rep. 2017;7:8066.","journal-title":"Sci Rep"},{"key":"2605_CR57","doi-asserted-by":"publisher","first-page":"3137","DOI":"10.1074\/jbc.272.6.3137","volume":"272","author":"JM Lehmann","year":"1997","unstructured":"Lehmann JM, Kliewer SA, Moore LB, Smith-Oliver TA, Oliver BB, Su J-L, et al. Activation of the Nuclear Receptor LXR by Oxysterols Defines a New Hormone Response Pathway. J Biol Chem. 1997;272:3137\u201340.","journal-title":"J Biol Chem"},{"key":"2605_CR58","doi-asserted-by":"publisher","first-page":"13000","DOI":"10.1074\/jbc.M114.564658","volume":"289","author":"S Liu","year":"2014","unstructured":"Liu S, Sheng L, Miao H, Saunders TL, MacDougald OA, Koenig RJ, et al. SRA Gene Knockout Protects against Diet-induced Obesity and Improves Glucose Tolerance. J Biol Chem. 2014;289:13000\u20139.","journal-title":"J Biol Chem"},{"key":"2605_CR59","doi-asserted-by":"publisher","first-page":"75","DOI":"10.2174\/157436208784223170","volume":"3","author":"M Fessler","year":"2008","unstructured":"Fessler M, Liver X. Receptor: Crosstalk Node for the Signaling of Lipid Metabolism, Carbohydrate Metabolism, and Innate Immunity. Curr Signal Transduct Ther. 2008;3:75\u201381.","journal-title":"Curr Signal Transduct Ther"},{"key":"2605_CR60","doi-asserted-by":"publisher","first-page":"35531","DOI":"10.1038\/srep35531","volume":"6","author":"G Chen","year":"2016","unstructured":"Chen G, Yu D, Nian X, Liu J, Koenig RJ, Xu B, et al. LncRNA SRA promotes hepatic steatosis through repressing the expression of adipose triglyceride lipase (ATGL). Sci Rep. 2016;6:35531.","journal-title":"Sci Rep"},{"key":"2605_CR61","doi-asserted-by":"publisher","first-page":"4783","DOI":"10.7150\/ijbs.100394","volume":"20","author":"J Rong","year":"2024","unstructured":"Rong J, Zhang Z, Peng X, Li P, Zhao T, Zhong Y. Mechanisms of hepatic and renal injury in lipid metabolism disorders in metabolic syndrome. Int J Biol Sci. 2024;20:4783\u201398.","journal-title":"Int J Biol Sci"},{"key":"2605_CR62","doi-asserted-by":"publisher","first-page":"91","DOI":"10.4103\/0366-6999.147824","volume":"128","author":"G Liu","year":"2015","unstructured":"Liu G, Zheng X, Xu Y, Lu J, Chen J, Huang X. Long Non-coding RNAs Expression Profile in HepG2 Cells Reveals the Potential Role of Long Non-coding RNAs in the Cholesterol Metabolism. Chin Med J (Engl). 2015;128:91\u20137.","journal-title":"Chin Med J (Engl)."},{"key":"2605_CR63","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1038\/s41419-020-03263-6","volume":"11","author":"X-H Yu","year":"2020","unstructured":"Yu X-H, Deng W-Y, Chen J-J, Xu X-D, Liu X-X, Chen L, et al. LncRNA kcnq1ot1 promotes lipid accumulation and accelerates atherosclerosis via functioning as a ceRNA through the miR-452-3p\/HDAC3\/ABCA1 axis. Cell Death Dis. 2020;11:1043.","journal-title":"Cell Death Dis"},{"key":"2605_CR64","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1016\/S0022-2275(20)31498-X","volume":"42","author":"AD Attie","year":"2001","unstructured":"Attie AD, Kastelein JP, Hayden MR. Pivotal role of ABCA1 in reverse cholesterol transport influencing HDL levels and susceptibility to atherosclerosis. J Lipid Res. 2001;42:1717\u201326.","journal-title":"J Lipid Res"},{"key":"2605_CR65","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.atherosclerosis.2010.01.011","volume":"211","author":"ML Fitzgerald","year":"2010","unstructured":"Fitzgerald ML, Mujawar Z, Tamehiro N. ABC transporters, atherosclerosis and inflammation. Atherosclerosis. 2010;211:361\u201370.","journal-title":"Atherosclerosis"},{"key":"2605_CR66","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1097\/00041433-200208000-00004","volume":"13","author":"JF Oram","year":"2002","unstructured":"Oram JF. ATP-binding cassette transporter A1 and cholesterol trafficking. Curr Opin Lipidol. 2002;13:373\u201381.","journal-title":"Curr Opin Lipidol."},{"key":"2605_CR67","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1161\/CIRCULATIONAHA.111.066589","volume":"125","author":"RS Rosenson","year":"2012","unstructured":"Rosenson RS, Brewer HB, Davidson WS, Fayad ZA, Fuster V, Goldstein J, et al. Cholesterol Efflux and Atheroprotection: Advancing the Concept of Reverse Cholesterol Transport. Circulation. 2012;125:1905\u201319.","journal-title":"Circulation"},{"key":"2605_CR68","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.3390\/ijms22041593","volume":"22","author":"L Jacobo-Albavera","year":"2021","unstructured":"Jacobo-Albavera L, Dom\u00ednguez-P\u00e9rez M, Medina-Leyte DJ, Gonz\u00e1lez-Garrido A, Villarreal-Molina T. The Role of the ATP-Binding Cassette A1 (ABCA1) in Human Disease. Int J Mol Sci. 2021;22:1593.","journal-title":"Int J Mol Sci"},{"key":"2605_CR69","doi-asserted-by":"crossref","unstructured":"Terasaka N. Sterol Efflux by ABCA1 and ABCG1. HDL Handb [Internet]. Elsevier; 2010 [cited 2025 Mar 5]. p. 199\u2013214. Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/B9780123821713100105","DOI":"10.1016\/B978-0-12-382171-3.10010-5"},{"key":"2605_CR70","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.cell.2008.04.052","volume":"134","author":"SJ Bensinger","year":"2008","unstructured":"Bensinger SJ, Bradley MN, Joseph SB, Zelcer N, Janssen EM, Hausner MA, et al. LXR Signaling Couples Sterol Metabolism to Proliferation in the Acquired Immune Response. Cell. 2008;134:97\u2013111.","journal-title":"Cell"},{"key":"2605_CR71","doi-asserted-by":"publisher","first-page":"L949","DOI":"10.1152\/ajplung.90394.2008","volume":"295","author":"CJ Delvecchio","year":"2008","unstructured":"Delvecchio CJ, Bilan P, Nair P, Capone JP. LXR-induced reverse cholesterol transport in human airway smooth muscle is mediated exclusively by ABCA1. Am J Physiol-Lung Cell Mol Physiol. 2008;295:L949\u201357.","journal-title":"Am J Physiol-Lung Cell Mol Physiol"},{"key":"2605_CR72","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1016\/j.cca.2009.12.027","volume":"411","author":"Y-W Hu","year":"2010","unstructured":"Hu Y-W, Zheng L, Wang Q. Regulation of cholesterol homeostasis by liver X receptors. Clin Chim Acta. 2010;411:617\u201325.","journal-title":"Clin Chim Acta"},{"key":"2605_CR73","doi-asserted-by":"publisher","first-page":"12097","DOI":"10.1073\/pnas.200367697","volume":"97","author":"A Venkateswaran","year":"2000","unstructured":"Venkateswaran A, Laffitte BA, Joseph SB, Mak PA, Wilpitz DC, Edwards PA, et al. Control of cellular cholesterol efflux by the nuclear oxysterol receptor LXR\u03b1. Proc Natl Acad Sci. 2000;97:12097\u2013102.","journal-title":"Proc Natl Acad Sci"},{"key":"2605_CR74","doi-asserted-by":"publisher","first-page":"e28766","DOI":"10.7554\/eLife.28766","volume":"6","author":"L Zhang","year":"2017","unstructured":"Zhang L, Rajbhandari P, Priest C, Sandhu J, Wu X, Temel R, et al. Inhibition of cholesterol biosynthesis through RNF145-dependent ubiquitination of SCAP. eLife. 2017;6:e28766.","journal-title":"eLife."},{"key":"2605_CR75","doi-asserted-by":"publisher","first-page":"895","DOI":"10.3892\/mmr.2012.758","volume":"5","author":"R Zhu","year":"2012","unstructured":"Zhu R, Ou Z, Ruan X, Gong J. Role of liver X receptors in cholesterol efflux and inflammatory signaling (Review). Mol Med Rep. 2012;5:895\u2013900.","journal-title":"Mol Med Rep"},{"key":"2605_CR76","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1038\/nm.4479","volume":"24","author":"T Sallam","year":"2018","unstructured":"Sallam T, Jones M, Thomas BJ, Wu X, Gilliland T, Qian K, et al. Transcriptional regulation of macrophage cholesterol efflux and atherogenesis by a long noncoding RNA. Nat Med. 2018;24:304\u201312.","journal-title":"Nat Med"},{"key":"2605_CR77","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.cca.2021.01.019","volume":"516","author":"S Zhang","year":"2021","unstructured":"Zhang S, Li L, Wang J, Zhang T, Ye T, Wang S, et al. Recent advances in the regulation of ABCA1 and ABCG1 by lncRNAs. Clin Chim Acta. 2021;516:100\u201310.","journal-title":"Clin Chim Acta"},{"key":"2605_CR78","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.729745","volume":"12","author":"S-F Huang","year":"2021","unstructured":"Huang S-F, Peng X-F, Jiang L, Hu CY, Ye W-C. LncRNAs as Therapeutic Targets and Potential Biomarkers for Lipid-Related Diseases. Front Pharmacol. 2021;12: 729745.","journal-title":"Front Pharmacol"},{"key":"2605_CR79","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1093\/cvr\/cvu140","volume":"103","author":"A Canfran-Duque","year":"2014","unstructured":"Canfran-Duque A, Ramirez CM, Goedeke L, Lin C-S, Fernandez-Hernando C. microRNAs and HDL life cycle. Cardiovasc Res. 2014;103:414\u201322.","journal-title":"Cardiovasc Res"},{"key":"2605_CR80","first-page":"929","volume":"1862","author":"B Liang","year":"2017","unstructured":"Liang B, Wang X, Song X, Bai R, Yang H, Yang Z, et al. MicroRNA-20a\/b regulates cholesterol efflux through post-transcriptional repression of ATP-binding cassette transporter A1. Biochim Biophys Acta BBA - Mol Cell Biol Lipids. 2017;1862:929\u201338.","journal-title":"Biochim Biophys Acta BBA - Mol Cell Biol Lipids"},{"key":"2605_CR81","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.phrs.2013.02.005","volume":"75","author":"A D\u00e1valos","year":"2013","unstructured":"D\u00e1valos A, Fern\u00e1ndez-Hernando C. From evolution to revolution: miRNAs as pharmacological targets for modulating cholesterol efflux and reverse cholesterol transport. Pharmacol Res. 2013;75:60\u201372.","journal-title":"Pharmacol Res"},{"key":"2605_CR82","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1038\/s41419-020-2645-3","volume":"11","author":"C Zhang","year":"2020","unstructured":"Zhang C, Ge S, Gong W, Xu J, Guo Z, Liu Z, et al. LncRNA ANRIL acts as a modular scaffold of WDR5 and HDAC3 complexes and promotes alteration of the vascular smooth muscle cell phenotype. Cell Death Dis. 2020;11:435.","journal-title":"Cell Death Dis"},{"key":"2605_CR83","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1080\/15476286.2015.1122164","volume":"13","author":"X Zhou","year":"2016","unstructured":"Zhou X, Han X, Wittfeldt A, Sun J, Liu C, Wang X, et al. Long non-coding RNA ANRIL regulates inflammatory responses as a novel component of NF-\u03baB pathway. RNA Biol. 2016;13:98\u2013108.","journal-title":"RNA Biol"},{"key":"2605_CR84","doi-asserted-by":"publisher","first-page":"4733","DOI":"10.12659\/MSM.904352","volume":"23","author":"F Wang","year":"2017","unstructured":"Wang F, Su X, Liu C, Wu M, Li B. Prognostic Value of Plasma Long Noncoding RNA ANRIL for In-Stent Restenosis. Med Sci Monit. 2017;23:4733\u20139.","journal-title":"Med Sci Monit"},{"key":"2605_CR85","doi-asserted-by":"publisher","first-page":"15340","DOI":"10.1038\/s41598-019-51921-3","volume":"9","author":"C-H Zhao","year":"2019","unstructured":"Zhao C-H, Cao H-T, Zhang J, Jia Q-W, An F-H, Chen Z-H, et al. DNA methylation of antisense noncoding RNA in the INK locus (ANRIL) is associated with coronary artery disease in a Chinese population. Sci Rep. 2019;9:15340.","journal-title":"Sci Rep"},{"key":"2605_CR86","doi-asserted-by":"publisher","first-page":"4516","DOI":"10.1093\/hmg\/ddt299","volume":"22","author":"G Bochenek","year":"2013","unstructured":"Bochenek G, H\u00e4sler R, El Mokhtari N-E, K\u00f6nig IR, Loos BG, Jepsen S, et al. The large non-coding RNA ANRIL, which is associated with atherosclerosis, periodontitis and several forms of cancer, regulates ADIPOR1, VAMP3 and C11ORF10. Hum Mol Genet. 2013;22:4516\u201327.","journal-title":"Hum Mol Genet"},{"key":"2605_CR87","doi-asserted-by":"publisher","first-page":"3881","DOI":"10.1074\/jbc.RA118.005050","volume":"294","author":"H Cho","year":"2019","unstructured":"Cho H, Shen G-Q, Wang X, Wang F, Archacki S, Li Y, et al. Long noncoding RNA ANRIL regulates endothelial cell activities associated with coronary artery disease by up-regulating CLIP1, EZR, and LYVE1 genes. J Biol Chem. 2019;294:3881\u201398.","journal-title":"J Biol Chem"},{"key":"2605_CR88","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1161\/ATVBAHA.109.196832","volume":"30","author":"LM Holdt","year":"2010","unstructured":"Holdt LM, Beutner F, Scholz M, Gielen S, G\u00e4bel G, Bergert H, et al. ANRIL Expression Is Associated With Atherosclerosis Risk at Chromosome 9p21. Arterioscler Thromb Vasc Biol. 2010;30:620\u20137.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2605_CR89","doi-asserted-by":"publisher","first-page":"145","DOI":"10.3389\/fcvm.2018.00145","volume":"5","author":"LM Holdt","year":"2018","unstructured":"Holdt LM, Teupser D. Long Noncoding RNA ANRIL: Lnc-ing Genetic Variation at the Chromosome 9p21 Locus to Molecular Mechanisms of Atherosclerosis. Front Cardiovasc Med. 2018;5:145.","journal-title":"Front Cardiovasc Med"},{"key":"2605_CR90","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.ncrna.2022.09.002","volume":"7","author":"I Gareev","year":"2022","unstructured":"Gareev I, Kudriashov V, Sufianov A, Begliarzade S, Ilyasova T, Liang Y, et al. The role of long non-coding RNA ANRIL in the development of atherosclerosis. Non-Coding RNA Res. 2022;7:212\u20136.","journal-title":"Non-Coding RNA Res"},{"key":"2605_CR91","doi-asserted-by":"publisher","first-page":"1113890","DOI":"10.3389\/fcvm.2023.1113890","volume":"10","author":"S Kettunen","year":"2023","unstructured":"Kettunen S, Ruotsalainen A-K, \u00d6rd T, Suoranta T, Heikkil\u00e4 J, Kaikkonen MU, et al. Deletion of the murine ortholog of human 9p21.3 locus promotes atherosclerosis by increasing macrophage proinflammatory activity. Front Cardiovasc Med. 2023;10:1113890.","journal-title":"Front Cardiovasc Med."},{"key":"2605_CR92","doi-asserted-by":"publisher","DOI":"10.1016\/j.mce.2023.112061","volume":"578","author":"X Lan","year":"2023","unstructured":"Lan X, Ren J, Du X, Zhang L, Wang S, Yang X, et al. lnc-HC ameliorates steatosis by promoting miR-130b-3p biogenesis and the assembly of an RNA-induced silencing complex. Mol Cell Endocrinol. 2023;578: 112061.","journal-title":"Mol Cell Endocrinol"},{"key":"2605_CR93","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1016\/j.omtn.2019.10.018","volume":"18","author":"X Lan","year":"2019","unstructured":"Lan X, Wu L, Wu N, Chen Q, Li Y, Du X, et al. Long Noncoding RNA lnc-HC Regulates PPAR\u03b3-Mediated Hepatic Lipid Metabolism through miR-130b-3p. Mol Ther - Nucleic Acids. 2019;18:954\u201365.","journal-title":"Mol Ther - Nucleic Acids"},{"key":"2605_CR94","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1002\/hep.28391","volume":"64","author":"X Lan","year":"2016","unstructured":"Lan X, Yan J, Ren J, Zhong B, Li J, Li Y, et al. A novel long noncoding RNA Lnc-HC binds hnRNPA2B1 to regulate expressions of Cyp7a1 and Abca1 in hepatocytic cholesterol metabolism. Hepatology. 2016;64:58\u201372.","journal-title":"Hepatology"},{"key":"2605_CR95","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.vph.2018.06.011","volume":"114","author":"X Zhang","year":"2019","unstructured":"Zhang X, Price NL, Fern\u00e1ndez-Hernando C. Non-coding RNAs in lipid metabolism. Vascul Pharmacol. 2019;114:93\u2013102.","journal-title":"Vascul Pharmacol"},{"key":"2605_CR96","doi-asserted-by":"crossref","unstructured":"Danielsson H. Present Status of Research on Catabolism and Excretion of Cholesterol. Adv Lipid Res [Internet]. Elsevier; 1963 [cited 2025 Mar 5]. p. 335\u201385. Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/B9781483199375500156","DOI":"10.1016\/B978-1-4831-9937-5.50015-6"},{"key":"2605_CR97","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/S1097-2765(00)00050-2","volume":"6","author":"TT Lu","year":"2000","unstructured":"Lu TT, Makishima M, Repa JJ, Schoonjans K, Kerr TA, Auwerx J, et al. Molecular Basis for Feedback Regulation of Bile Acid Synthesis by Nuclear Receptors. Mol Cell. 2000;6:507\u201315.","journal-title":"Mol Cell"},{"key":"2605_CR98","doi-asserted-by":"publisher","first-page":"S120","DOI":"10.1194\/jlr.R800026-JLR200","volume":"50","author":"DW Russell","year":"2009","unstructured":"Russell DW. Fifty years of advances in bile acid synthesis and metabolism. J Lipid Res. 2009;50:S120\u20135.","journal-title":"J Lipid Res"},{"key":"2605_CR99","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1146\/annurev.biochem.72.121801.161712","volume":"72","author":"DW Russell","year":"2003","unstructured":"Russell DW. The Enzymes, Regulation, and Genetics of Bile Acid Synthesis. Annu Rev Biochem. 2003;72:137\u201374.","journal-title":"Annu Rev Biochem"},{"key":"2605_CR100","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1055\/s-2008-1040410","volume":"12","author":"Z Vlahcevic","year":"1992","unstructured":"Vlahcevic Z, Pandak W, Heuman D, Hylemon P. Function and Regulation of Hydroxylases Involved in the Bile Acid Biosynthesis Pathways. Semin Liver Dis. 1992;12:403\u201319.","journal-title":"Semin Liver Dis"},{"key":"2605_CR101","doi-asserted-by":"publisher","unstructured":"Chiang JYL. Bile Acid Metabolism and Signaling. In: Terjung R, editor. Compr Physiol [Internet]. 1st ed. Wiley; 2013 [cited 2025 Mar 5]. p. 1191\u2013212. Available from: https:\/\/onlinelibrary.wiley.com\/doi\/https:\/\/doi.org\/10.1002\/cphy.c120023","DOI":"10.1002\/cphy.c120023"},{"key":"2605_CR102","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1210\/er.2000-0035","volume":"23","author":"JYL Chiang","year":"2002","unstructured":"Chiang JYL. Bile Acid Regulation of Gene Expression: Roles of Nuclear Hormone Receptors. Endocr Rev. 2002;23:443\u201363.","journal-title":"Endocr Rev"},{"key":"2605_CR103","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1194\/jlr.M071266","volume":"58","author":"X Liu","year":"2017","unstructured":"Liu X, Henkel AS, LeCuyer BE, Hubchak SC, Schipma MJ, Zhang E, et al. Hepatic deletion of X-box binding protein 1 impairs bile acid metabolism in mice. J Lipid Res. 2017;58:504\u201311.","journal-title":"J Lipid Res"},{"key":"2605_CR104","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s43042-025-00658-y","volume":"26","author":"M Bayat","year":"2025","unstructured":"Bayat M, Mokhtari M, Mokhtari MJ, Gharbi N, Tabrizi R, Salehi MS, et al. Unveiling the association between long non-coding RNAs (RP5\u2013833A20.1, DYNLRB2\u20132, and APOA1-AS) and ischemic stroke: exploring biomarkers, and clinical implications. Egypt J Med Hum Genet. 2025;26:30.","journal-title":"Egypt J Med Hum Genet."},{"key":"2605_CR105","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1194\/jlr.M044669","volume":"55","author":"Y-W Hu","year":"2014","unstructured":"Hu Y-W, Yang J-Y, Ma X, Chen Z-P, Hu Y-R, Zhao J-Y, et al. A lincRNA-DYNLRB2-2\/GPR119\/GLP-1R\/ABCA1-dependent signal transduction pathway is essential for the regulation of cholesterol homeostasis. J Lipid Res. 2014;55:681\u201397.","journal-title":"J Lipid Res"},{"key":"2605_CR106","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1016\/j.gendis.2021.06.010","volume":"9","author":"F Liu","year":"2022","unstructured":"Liu F, Zhu X, Jiang X, Li S, Lv Y. Transcriptional control by HNF-1: Emerging evidence showing its role in lipid metabolism and lipid metabolism disorders. Genes Dis. 2022;9:1248\u201357.","journal-title":"Genes Dis"},{"key":"2605_CR107","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1161\/ATVBAHA.114.304296","volume":"35","author":"Y-W Hu","year":"2015","unstructured":"Hu Y-W, Zhao J-Y, Li S-F, Huang J-L, Qiu Y-R, Ma X, et al. RP5\u2013833A20.1\/miR-382\u20135p\/NFIA\u2013Dependent Signal Transduction Pathway Contributes to the Regulation of Cholesterol Homeostasis and Inflammatory Reaction. Arterioscler Thromb Vasc Biol. 2015;35:87\u2013101.","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"2605_CR108","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1515\/hsz-2018-0461","volume":"400","author":"Y Li","year":"2019","unstructured":"Li Y, Sun T, Shen S, Wang L, Yan J. LncRNA DYNLRB2-2 inhibits THP-1 macrophage foam cell formation by enhancing autophagy. Biol Chem. 2019;400:1047\u201357.","journal-title":"Biol Chem"},{"key":"2605_CR109","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.1002\/jcb.26352","volume":"119","author":"Y Li","year":"2018","unstructured":"Li Y, Shen S, Ding S, Wang L. LincRNA DYN-LRB2-2 upregulates cholesterol efflux by decreasing TLR2 expression in macrophages. J Cell Biochem. 2018;119:1911\u201321.","journal-title":"J Cell Biochem"},{"key":"2605_CR110","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.coi.2018.08.001","volume":"56","author":"EV Dang","year":"2019","unstructured":"Dang EV, Cyster JG. Loss of sterol metabolic homeostasis triggers inflammasomes \u2014 how and why. Curr Opin Immunol. 2019;56:1\u20139.","journal-title":"Curr Opin Immunol"},{"key":"2605_CR111","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2020.564604","volume":"11","author":"Q Meng","year":"2020","unstructured":"Meng Q, Pu L, Luo X, Wang B, Li F, Liu B. Regulatory Roles of Related Long Non-coding RNAs in the Process of Atherosclerosis. Front Physiol. 2020;11: 564604.","journal-title":"Front Physiol"},{"key":"2605_CR112","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2018\/3897295","volume":"2018","author":"M Di Franco","year":"2018","unstructured":"Di Franco M, Lucchino B, Conti F, Valesini G, Spinelli FR. Asymmetric Dimethyl Arginine as a Biomarker of Atherosclerosis in Rheumatoid Arthritis. Mediators Inflamm. 2018;2018:1\u201313.","journal-title":"Mediators Inflamm"},{"key":"2605_CR113","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1097\/MOL.0000000000000704","volume":"31","author":"GS Getz","year":"2020","unstructured":"Getz GS, Reardon CA. Atherosclerosis: cell biology and lipoproteins. Curr Opin Lipidol. 2020;31:286\u201390.","journal-title":"Curr Opin Lipidol"},{"key":"2605_CR114","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.gde.2004.04.012","volume":"14","author":"J Scott","year":"2004","unstructured":"Scott J. Pathophysiology and biochemistry of cardiovascular disease. Curr Opin Genet Dev. 2004;14:271\u20139.","journal-title":"Curr Opin Genet Dev"},{"key":"2605_CR115","doi-asserted-by":"publisher","first-page":"263","DOI":"10.3389\/fcell.2019.00263","volume":"7","author":"X Cheng","year":"2019","unstructured":"Cheng X, Chen Z, Wan Y, Zhou Q, Wang H, Zhu H. Long Non-coding RNA H19 Suppression Protects the Endothelium Against Hyperglycemic-Induced Inflammation via Inhibiting Expression of miR-29b Target Gene Vascular Endothelial Growth Factor a Through Activation of the Protein Kinase B\/Endothelial Nitric Oxide Synthase Pathway. Front Cell Dev Biol. 2019;7:263.","journal-title":"Front Cell Dev Biol"},{"key":"2605_CR116","doi-asserted-by":"publisher","first-page":"32","DOI":"10.3389\/fneur.2019.00032","volume":"10","author":"Y Huang","year":"2019","unstructured":"Huang Y, Wang L, Mao Y, Nan G. Long Noncoding RNA-H19 Contributes to Atherosclerosis and Induces Ischemic Stroke via the Upregulation of Acid Phosphatase 5. Front Neurol. 2019;10:32.","journal-title":"Front Neurol"},{"key":"2605_CR117","doi-asserted-by":"publisher","first-page":"BSR20181722","DOI":"10.1042\/BSR20181722","volume":"39","author":"J Liu","year":"2019","unstructured":"Liu J, Tang T, Wang GD, Liu B. LncRNA-H19 promotes hepatic lipogenesis by directly regulating miR-130a\/PPAR\u03b3 axis in non-alcoholic fatty liver disease. Biosci Rep. 2019;39:BSR20181722.","journal-title":"Biosci Rep."},{"key":"2605_CR118","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s10020-020-00196-w","volume":"26","author":"X Shi","year":"2020","unstructured":"Shi X, Wei Y-T, Li H, Jiang T, Zheng X-L, Yin K, et al. Long non-coding RNA H19 in atherosclerosis: what role? Mol Med. 2020;26:72.","journal-title":"Mol Med"},{"key":"2605_CR119","doi-asserted-by":"publisher","first-page":"7491","DOI":"10.1038\/s41598-017-07611-z","volume":"7","author":"Z Zhang","year":"2017","unstructured":"Zhang Z, Gao W, Long Q-Q, Zhang J, Li Y-F, Liu D-C, et al. Increased plasma levels of lncRNA H19 and LIPCAR are associated with increased risk of coronary artery disease in a Chinese population. Sci Rep. 2017;7:7491.","journal-title":"Sci Rep"},{"key":"2605_CR120","first-page":"1","volume":"2019","author":"H Zhou","year":"2019","unstructured":"Zhou H, Wang B, Yang Y, Jia Q, Zhang A, Qi Z, et al. Long Noncoding RNAs in Pathological Cardiac Remodeling: A Review of the Update Literature. BioMed Res Int. 2019;2019:1\u201311.","journal-title":"BioMed Res Int"},{"key":"2605_CR121","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1002\/mc.10075","volume":"35","author":"S Ayesh","year":"2002","unstructured":"Ayesh S, Matouk I, Schneider T, Ohana P, Laster M, Al-Sharef W, et al. Possible physiological role of H19 RNA. Mol Carcinog. 2002;35:63\u201374.","journal-title":"Mol Carcinog"},{"key":"2605_CR122","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1016\/j.biopha.2018.06.007","volume":"105","author":"Y Fang","year":"2018","unstructured":"Fang Y, Hu J, Wang Z, Zong H, Zhang L, Zhang R, et al. LncRNA H19 functions as an Aquaporin 1 competitive endogenous RNA to regulate microRNA-874 expression in LPS sepsis. Biomed Pharmacother. 2018;105:1183\u201391.","journal-title":"Biomed Pharmacother"},{"key":"2605_CR123","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1172\/JCI118543","volume":"97","author":"DK Han","year":"1996","unstructured":"Han DK, Khaing ZZ, Pollock RA, Haudenschild CC, Liau G. H19, a marker of developmental transition, is reexpressed in human atherosclerotic plaques and is regulated by the insulin family of growth factors in cultured rabbit smooth muscle cells. J Clin Invest. 1996;97:1276\u201385.","journal-title":"J Clin Invest"},{"key":"2605_CR124","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.yjmcc.2019.04.004","volume":"131","author":"Y Sun","year":"2019","unstructured":"Sun Y, Zhong L, He X, Wang S, Lai Y, Wu W, et al. LncRNA H19 promotes vascular inflammation and abdominal aortic aneurysm formation by functioning as a competing endogenous RNA. J Mol Cell Cardiol. 2019;131:66\u201381.","journal-title":"J Mol Cell Cardiol"},{"key":"2605_CR125","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s12929-018-0418-4","volume":"25","author":"L Zhang","year":"2018","unstructured":"Zhang L, Cheng H, Yue Y, Li S, Zhang D, He R. H19 knockdown suppresses proliferation and induces apoptosis by regulating miR-148b\/WNT\/\u03b2-catenin in ox-LDL -stimulated vascular smooth muscle cells. J Biomed Sci. 2018;25:11.","journal-title":"J Biomed Sci"},{"key":"2605_CR126","first-page":"4491","volume":"23","author":"Z-F Li","year":"2019","unstructured":"Li Z-F, Shu X-J, Chang Y-W, Liu S-Y, Wang W-H. Effect of lncRNA H19 on the apoptosis of vascular endothelial cells in arteriosclerosis obliterans via the NF-\u03baB pathway. Eur Rev Med Pharmacol Sci. 2019;23:4491\u20137.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"2605_CR127","first-page":"322","volume":"21","author":"J-X Pan","year":"2017","unstructured":"Pan J-X. LncRNA H19 promotes atherosclerosis by regulating MAPK and NF-kB signaling pathway. Eur Rev Med Pharmacol Sci. 2017;21:322\u20138.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"2605_CR128","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1002\/biof.1659","volume":"46","author":"J Yang","year":"2020","unstructured":"Yang J, Li Y, Wang L, Zhang Z, Li Z, Jia Q. LncRNA H19 aggravates TNF -\u03b1-induced inflammatory injury via TAK1 pathway in MH7A cells. BioFactors. 2020;46:813\u201320.","journal-title":"BioFactors"},{"key":"2605_CR129","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.molimm.2017.11.017","volume":"93","author":"Y Han","year":"2018","unstructured":"Han Y, Ma J, Wang J, Wang L. Silencing of H19 inhibits the adipogenesis and inflammation response in ox-LDL-treated Raw264.7 cells by up-regulating miR-130b. Mol Immunol. 2018;93:107\u201314.","journal-title":"Mol Immunol."},{"key":"2605_CR130","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.omtn.2019.10.034","volume":"19","author":"X-D Meng","year":"2020","unstructured":"Meng X-D, Yao H-H, Wang L-M, Yu M, Shi S, Yuan Z-X, et al. Knockdown of GAS5 Inhibits Atherosclerosis Progression via Reducing EZH2-Mediated ABCA1 Transcription in ApoE\u2212\/\u2212 Mice. Mol Ther - Nucleic Acids. 2020;19:84\u201396.","journal-title":"Mol Ther - Nucleic Acids"},{"key":"2605_CR131","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2019.109302","volume":"118","author":"S Shen","year":"2019","unstructured":"Shen S, Zheng X, Zhu Z, Zhao S, Zhou Q, Song Z, et al. Silencing of GAS5 represses the malignant progression of atherosclerosis through upregulation of miR-135a. Biomed Pharmacother. 2019;118: 109302.","journal-title":"Biomed Pharmacother"},{"key":"2605_CR132","doi-asserted-by":"publisher","first-page":"2211","DOI":"10.1016\/j.jacc.2015.09.012","volume":"66","author":"A Rohatgi","year":"2015","unstructured":"Rohatgi A, Grundy SM. Cholesterol Efflux Capacity as a Therapeutic Target. J Am Coll Cardiol. 2015;66:2211\u20133.","journal-title":"J Am Coll Cardiol"},{"key":"2605_CR133","doi-asserted-by":"publisher","first-page":"32336","DOI":"10.1074\/jbc.M109.047472","volume":"284","author":"C Tang","year":"2009","unstructured":"Tang C, Liu Y, Kessler PS, Vaughan AM, Oram JF. The Macrophage Cholesterol Exporter ABCA1 Functions as an Anti-inflammatory Receptor. J Biol Chem. 2009;284:32336\u201343.","journal-title":"J Biol Chem"},{"key":"2605_CR134","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.bbrc.2010.04.027","volume":"395","author":"D Ye","year":"2010","unstructured":"Ye D, Meurs I, Ohigashi M, Calpe-Berdiel L, Habets KLL, Zhao Y, et al. Macrophage ABCA5 deficiency influences cellular cholesterol efflux and increases susceptibility to atherosclerosis in female LDLr knockout mice. Biochem Biophys Res Commun. 2010;395:387\u201394.","journal-title":"Biochem Biophys Res Commun"},{"key":"2605_CR135","doi-asserted-by":"publisher","first-page":"14405","DOI":"10.1002\/jcb.28695","volume":"120","author":"S Chen","year":"2019","unstructured":"Chen S, Chen H, Yu C, Lu R, Song T, Wang X, et al. Long noncoding RNA myocardial infarction associated transcript promotes the development of thoracic aortic by targeting microRNA-145 via the PI3K\/Akt signaling pathway. J Cell Biochem. 2019;120:14405\u201313.","journal-title":"J Cell Biochem"},{"key":"2605_CR136","doi-asserted-by":"publisher","first-page":"G559","DOI":"10.1152\/ajpgi.00242.2017","volume":"314","author":"X Huang","year":"2018","unstructured":"Huang X, Gao Y, Qin J, Lu S. lncRNA MIAT promotes proliferation and invasion of HCC cells via sponging miR-214. Am J Physiol-Gastrointest Liver Physiol. 2018;314:G559\u201365.","journal-title":"Am J Physiol-Gastrointest Liver Physiol"},{"key":"2605_CR137","doi-asserted-by":"publisher","first-page":"42657","DOI":"10.1038\/srep42657","volume":"7","author":"X Qu","year":"2017","unstructured":"Qu X, Du Y, Shu Y, Gao M, Sun F, Luo S, et al. MIAT Is a Pro-fibrotic Long Non-coding RNA Governing Cardiac Fibrosis in Post-infarct Myocardium. Sci Rep. 2017;7:42657.","journal-title":"Sci Rep"},{"key":"2605_CR138","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s12929-018-0427-3","volume":"25","author":"C Sun","year":"2018","unstructured":"Sun C, Huang L, Li Z, Leng K, Xu Y, Jiang X, et al. Long non-coding RNA MIAT in development and disease: a new player in an old game. J Biomed Sci. 2018;25:23.","journal-title":"J Biomed Sci"},{"key":"2605_CR139","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2019\/6280194","volume":"2019","author":"J Tan","year":"2019","unstructured":"Tan J, Liu S, Jiang Q, Yu T, Huang K. LncRNA-MIAT Increased in Patients with Coronary Atherosclerotic Heart Disease. Cardiol Res Pract. 2019;2019:1\u20135.","journal-title":"Cardiol Res Pract"},{"key":"2605_CR140","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1038\/s41419-019-1409-4","volume":"10","author":"Z Ye","year":"2019","unstructured":"Ye Z, Yang S, Xia Y, Hu R, Chen S, Li B, et al. LncRNA MIAT sponges miR-149-5p to inhibit efferocytosis in advanced atherosclerosis through CD47 upregulation. Cell Death Dis. 2019;10:138.","journal-title":"Cell Death Dis"},{"key":"2605_CR141","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1016\/j.biopha.2017.11.052","volume":"97","author":"X Zhong","year":"2018","unstructured":"Zhong X, Ma X, Zhang L, Li Y, Li Y, He R. MIAT promotes proliferation and hinders apoptosis by modulating miR-181b\/STAT3 axis in ox-LDL-induced atherosclerosis cell models. Biomed Pharmacother. 2018;97:1078\u201385.","journal-title":"Biomed Pharmacother"},{"key":"2605_CR142","doi-asserted-by":"publisher","first-page":"e2929","DOI":"10.1038\/cddis.2017.321","volume":"8","author":"X Zhou","year":"2017","unstructured":"Zhou X, Zhang W, Jin M, Chen J, Xu W, Kong X. lncRNA MIAT functions as a competing endogenous RNA to upregulate DAPK2 by sponging miR-22-3p in diabetic cardiomyopathy. Cell Death Dis. 2017;8:e2929\u2013e2929.","journal-title":"Cell Death Dis"},{"key":"2605_CR143","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1177\/0960327120975122","volume":"40","author":"M Shi","year":"2021","unstructured":"Shi M, He Y, Zhang Y, Guo X, Lin J, Wang W, et al. RETRACTED: LncRNA MIAT regulated by selenium and T-2 toxin increases NF-\u03baB-p65 activation, promoting the progress of Kashin-Beck Disease. Hum Exp Toxicol. 2021;40:869\u201381.","journal-title":"Hum Exp Toxicol"},{"key":"2605_CR144","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1007\/s10528-020-09976-9","volume":"58","author":"P-C Xing","year":"2020","unstructured":"Xing P-C, An P, Hu G-Y, Wang D-L, Zhou M-J. LncRNA MIAT Promotes Inflammation and Oxidative Stress in Sepsis-Induced Cardiac Injury by Targeting miR-330-5p\/TRAF6\/NF-\u03baB Axis. Biochem Genet. 2020;58:783\u2013800.","journal-title":"Biochem Genet"},{"key":"2605_CR145","doi-asserted-by":"publisher","first-page":"9244","DOI":"10.3390\/ijms25179244","volume":"25","author":"A Gluba-Sagr","year":"2024","unstructured":"Gluba-Sagr A, Franczyk B, Rysz-G\u00f3rzy\u0144ska A, Olszewski R, Rysz J. The Role of Selected lncRNAs in Lipid Metabolism and Cardiovascular Disease Risk. Int J Mol Sci. 2024;25:9244.","journal-title":"Int J Mol Sci"},{"key":"2605_CR146","doi-asserted-by":"publisher","unstructured":"Yang S, Sun J. LncRNA SRA deregulation contributes to the development of atherosclerosis by causing dysfunction of endothelial cells through repressing the expression of adipose triglyceride lipase. Mol Med Rep [Internet]. 2018 [cited 2025 Apr 8]; Available from: http:\/\/www.spandidos-publications.com\/https:\/\/doi.org\/10.3892\/mmr.2018.9497","DOI":"10.3892\/mmr.2018.9497"},{"key":"2605_CR147","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1038\/s42255-018-0004-9","volume":"1","author":"EJ Hennessy","year":"2018","unstructured":"Hennessy EJ, Van Solingen C, Scacalossi KR, Ouimet M, Afonso MS, Prins J, et al. The long noncoding RNA CHROME regulates cholesterol homeostasis in primates. Nat Metab. 2018;1:98\u2013110.","journal-title":"Nat Metab"},{"key":"2605_CR148","doi-asserted-by":"publisher","first-page":"382","DOI":"10.3390\/ph13110382","volume":"13","author":"I Paez","year":"2020","unstructured":"Paez I, Prado Y, Ubilla CG, Zambrano T, Salazar LA. Atorvastatin Increases the Expression of Long Non-Coding RNAs ARSR and CHROME in Hypercholesterolemic Patients: A Pilot Study. Pharmaceuticals. 2020;13:382.","journal-title":"Pharmaceuticals"},{"key":"2605_CR149","doi-asserted-by":"publisher","unstructured":"Van Solingen C, Cyr Y, Barcia Duran JG, Eberhardt N, Smyrnis P, Giannarelli C, et al. Abstract 3050: The Multifaceted Roles Of Long Noncoding Rna CHROMR In Cardiovascular Disease. Arterioscler Thromb Vasc Biol [Internet]. 2024 [cited 2025 Mar 5];44. Available from: https:\/\/www.ahajournals.org\/doi\/https:\/\/doi.org\/10.1161\/atvb.44.suppl_1.3050","DOI":"10.1161\/atvb.44.suppl_1.3050"},{"key":"2605_CR150","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.jacl.2011.03.001","volume":"5","author":"AC Goldberg","year":"2011","unstructured":"Goldberg AC, Hopkins PN, Toth PP, Ballantyne CM, Rader DJ, Robinson JG, et al. Familial Hypercholesterolemia: Screening, diagnosis and management of pediatric and adult patients. J Clin Lipidol. 2011;5:133\u201340.","journal-title":"J Clin Lipidol"},{"key":"2605_CR151","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1016\/j.jacl.2018.05.011","volume":"12","author":"JW Balder","year":"2018","unstructured":"Balder JW, Lansberg PJ, Hof MH, Wiegman A, Hutten BA, Kuivenhoven JA. Pediatric lipid reference values in the general population: The Dutch lifelines cohort study. J Clin Lipidol. 2018;12:1208\u201316.","journal-title":"J Clin Lipidol"},{"key":"2605_CR152","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/1471-230X-6-33","volume":"6","author":"G Bedogni","year":"2006","unstructured":"Bedogni G, Bellentani S, Miglioli L, Masutti F, Passalacqua M, Castiglione A, et al. The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population. BMC Gastroenterol. 2006;6:33.","journal-title":"BMC Gastroenterol"},{"key":"2605_CR153","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1373\/clinchem.2018.287037","volume":"64","author":"MR Langlois","year":"2018","unstructured":"Langlois MR, Chapman MJ, Cobbaert C, Mora S, Remaley AT, Ros E, et al. Quantifying Atherogenic Lipoproteins: Current and Future Challenges in the Era of Personalized Medicine and Very Low Concentrations of LDL Cholesterol. A Consensus Statement from EAS and EFLM. Clin Chem. 2018;64:1006\u201333.","journal-title":"Clin Chem."},{"key":"2605_CR154","doi-asserted-by":"publisher","first-page":"109","DOI":"10.3949\/ccjm.87a.19021","volume":"87","author":"NP Shah","year":"2020","unstructured":"Shah NP, Ahmed HM, Wilson Tang WH. Familial hypercholesterolemia: Detect, treat, and ask about family. Cleve Clin J Med. 2020;87:109\u201320.","journal-title":"Cleve Clin J Med"},{"key":"2605_CR155","doi-asserted-by":"publisher","unstructured":"Cenarro A, Galicia-Garcia U, Marco-Benedi V, Bea AM, Martin C, Civeira F. Abstract 12043: The Genetic Variant P.(Lys3344Glu) in APOB Causes Familial Hypercholesterolemia. Circulation [Internet]. 2022 [cited 2025 Mar 5];146. Available from: https:\/\/www.ahajournals.org\/doi\/https:\/\/doi.org\/10.1161\/circ.146.suppl_1.12043","DOI":"10.1161\/circ.146.suppl_1.12043"},{"key":"2605_CR156","doi-asserted-by":"publisher","first-page":"3224","DOI":"10.3390\/ijms24043224","volume":"24","author":"MD Di Taranto","year":"2023","unstructured":"Di Taranto MD, Fortunato G. Genetic Heterogeneity of Familial Hypercholesterolemia: Repercussions for Molecular Diagnosis. Int J Mol Sci. 2023;24:3224.","journal-title":"Int J Mol Sci"},{"key":"2605_CR157","doi-asserted-by":"publisher","first-page":"262","DOI":"10.3390\/metabo12030262","volume":"12","author":"Y Ghaleb","year":"2022","unstructured":"Ghaleb Y, Elbitar S, Philippi A, El Khoury P, Azar Y, Andrianirina M, et al. Whole Exome\/Genome Sequencing Joint Analysis of a Family with Oligogenic Familial Hypercholesterolemia. Metabolites. 2022;12:262.","journal-title":"Metabolites"},{"key":"2605_CR158","doi-asserted-by":"publisher","first-page":"522","DOI":"10.18699\/VJGB-23-63","volume":"27","author":"DE Ivanoshchuk","year":"2023","unstructured":"Ivanoshchuk DE, Kolker AB, Timoshchenko OV, Semaev SE, Shakhtshneider EV. Searching for new genes associated with the familial hypercholesterolemia phenotype using whole-genome sequencing and machine learning. Vavilov J Genet Breed. 2023;27:522\u20139.","journal-title":"Vavilov J Genet Breed"},{"key":"2605_CR159","doi-asserted-by":"publisher","DOI":"10.1016\/j.jlr.2023.100490","volume":"65","author":"AM Medeiros","year":"2024","unstructured":"Medeiros AM, Alves AC, Miranda B, Chora JR, Bourbon M, Bourbon M, et al. Unraveling the genetic background of individuals with a clinical familial hypercholesterolemia phenotype. J Lipid Res. 2024;65: 100490.","journal-title":"J Lipid Res"},{"key":"2605_CR160","doi-asserted-by":"publisher","first-page":"9241","DOI":"10.1038\/s41598-023-34639-1","volume":"13","author":"RA Zorzo","year":"2023","unstructured":"Zorzo RA, Suen VMM, Santos JE, Silva-Jr WA, Suazo VK, Honorato ALSC, et al. LDLR gene\u2019s promoter region hypermethylation in patients with familial hypercholesterolemia. Sci Rep. 2023;13:9241.","journal-title":"Sci Rep"},{"key":"2605_CR161","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1038\/ejhg.2012.276","volume":"21","author":"A Posafalvi","year":"2013","unstructured":"Posafalvi A, Herkert JC, Sinke RJ, Van Den Berg MP, Mogensen J, Jongbloed JDH, et al. Clinical utility gene card for: Dilated Cardiomyopathy (CMD). Eur J Hum Genet. 2013;21:1185\u20131185.","journal-title":"Eur J Hum Genet"},{"key":"2605_CR162","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.jacl.2018.12.003","volume":"13","author":"IK Luirink","year":"2019","unstructured":"Luirink IK, Braamskamp MJAM, Wiegman A, Hartgers ML, Sjouke B, Defesche JC, et al. The clinical and molecular diversity of homozygous familial hypercholesterolemia in children: Results from the GeneTics of clinical homozygous hypercholesterolemia (GoTCHA) study. J Clin Lipidol. 2019;13:272\u20138.","journal-title":"J Clin Lipidol"},{"key":"2605_CR163","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/s11883-023-01091-5","volume":"25","author":"AM Medeiros","year":"2023","unstructured":"Medeiros AM, Bourbon M. Genetic Testing in Familial Hypercholesterolemia: Is It for Everyone? Curr Atheroscler Rep. 2023;25:127\u201332.","journal-title":"Curr Atheroscler Rep"},{"key":"2605_CR164","doi-asserted-by":"publisher","first-page":"e215","DOI":"10.1542\/peds.2006-1812","volume":"120","author":"US Preventive Services Task Force","year":"2007","unstructured":"US Preventive Services Task Force. Screening for Lipid Disorders in Children: US Preventive Services Task Force Recommendation Statement. Pediatrics. 2007;120:e215\u20139.","journal-title":"Pediatrics"},{"key":"2605_CR165","doi-asserted-by":"publisher","first-page":"107","DOI":"10.4103\/0974-2069.132478","volume":"7","author":"M Varghese","year":"2014","unstructured":"Varghese M. Familial hypercholesterolemia: A review. Ann Pediatr Cardiol. 2014;7:107.","journal-title":"Ann Pediatr Cardiol"},{"key":"2605_CR166","doi-asserted-by":"publisher","first-page":"2401939","DOI":"10.1002\/advs.202401939","volume":"11","author":"S Kaimala","year":"2024","unstructured":"Kaimala S, Lootah SS, Mehra N, Kumar CA, Marzooqi SA, Sampath P, et al. The Long Non-Coding RNA Obesity-Related (Obr) Contributes To Lipid Metabolism Through Epigenetic Regulation. Adv Sci. 2024;11:2401939.","journal-title":"Adv Sci"},{"key":"2605_CR167","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1186\/s12864-019-6093-3","volume":"20","author":"K Muret","year":"2019","unstructured":"Muret K, D\u00e9sert C, Lagoutte L, Boutin M, Gondret F, Zerjal T, et al. Long noncoding RNAs in lipid metabolism: literature review and conservation analysis across species. BMC Genomics. 2019;20:882.","journal-title":"BMC Genomics"},{"key":"2605_CR168","doi-asserted-by":"publisher","DOI":"10.3389\/fvets.2022.998796","volume":"9","author":"G Wang","year":"2022","unstructured":"Wang G, Li M, Wang Y, Wang B, Pu H, Mao J, et al. Characterization of differentially expressed and lipid metabolism-related lncRNA-mRNA interaction networks during the growth of liver tissue through rabbit models. Front Vet Sci. 2022;9: 998796.","journal-title":"Front Vet Sci"},{"key":"2605_CR169","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1089\/dna.2021.0220","volume":"41","author":"L Yu","year":"2022","unstructured":"Yu L, Tai L, Gao J, Sun M, Liu S, Huang T, et al. A New lncRNA, lnc-LLMA, Regulates Lipid Metabolism in Pig Hepatocytes. DNA Cell Biol. 2022;41:202\u201314.","journal-title":"DNA Cell Biol"},{"key":"2605_CR170","doi-asserted-by":"crossref","unstructured":"Zeng Y, Ren K, Zhu X, Zheng Z, Yi G. Long Noncoding RNAs. Adv Clin Chem [Internet]. Elsevier; 2018 [cited 2025 Mar 5]. p. 1\u201336. Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0065242318300362","DOI":"10.1016\/bs.acc.2018.07.001"},{"key":"2605_CR171","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2021.691824","volume":"12","author":"B Zhang","year":"2021","unstructured":"Zhang B, Xu S, Liu J, Xie Y, Xiaobo S. Long Noncoding RNAs: Novel Important Players in Adipocyte Lipid Metabolism and Derivative Diseases. Front Physiol. 2021;12: 691824.","journal-title":"Front Physiol"},{"key":"2605_CR172","doi-asserted-by":"publisher","first-page":"1419808","DOI":"10.3389\/fonc.2024.1419808","volume":"14","author":"SS Blancas-Zugarazo","year":"2024","unstructured":"Blancas-Zugarazo SS, Langley E, Hidalgo-Miranda A. Exosomal lncRNAs as regulators of breast cancer chemoresistance and metastasis and their potential use as biomarkers. Front Oncol. 2024;14:1419808.","journal-title":"Front Oncol"},{"key":"2605_CR173","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbagrm.2024.195061","volume":"1867","author":"P Guha","year":"2024","unstructured":"Guha P, Chini A, Rishi A, Mandal SS. Long noncoding RNAs in ubiquitination, protein degradation, and human diseases. Biochim Biophys Acta BBA - Gene Regul Mech. 2024;1867: 195061.","journal-title":"Biochim Biophys Acta BBA - Gene Regul Mech"},{"key":"2605_CR174","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1016\/j.ncrna.2024.06.010","volume":"9","author":"X Li","year":"2024","unstructured":"Li X, Wu Y, Jin Y. Exosomal LncRNAs and CircRNAs in lung cancer: Emerging regulators and potential therapeutic targets. Non-Coding RNA Res. 2024;9:1069\u201379.","journal-title":"Non-Coding RNA Res"},{"key":"2605_CR175","doi-asserted-by":"crossref","unstructured":"Papoutsoglou P, Morillon A. Extracellular Vesicle lncRNA Are Key Biomolecules for Cell-to-Cell Communication and Circulating Cancer Biomarkers [Internet]. Biology and Life Sciences; 2024 [cited 2025 Mar 5]. Available from: https:\/\/www.preprints.org\/manuscript\/202410.0469\/v1","DOI":"10.20944\/preprints202410.0469.v1"},{"key":"2605_CR176","doi-asserted-by":"publisher","first-page":"1522491","DOI":"10.3389\/fonc.2024.1522491","volume":"14","author":"H Yan","year":"2025","unstructured":"Yan H, Jiang N, Li X, Lin C, Wang F, Zhang J, et al. Exosomal lncRNAs as diagnostic and therapeutic targets in multiple myeloma. Front Oncol. 2025;14:1522491.","journal-title":"Front Oncol"},{"key":"2605_CR177","doi-asserted-by":"publisher","first-page":"142","DOI":"10.3892\/or.2024.8801","volume":"52","author":"N Zhang","year":"2024","unstructured":"Zhang N, Wen K. The role of lncRNA binding to RNA-binding proteins to regulate mRNA stability in cancer progression and drug resistance mechanisms (Review). Oncol Rep. 2024;52:142.","journal-title":"Oncol Rep"},{"key":"2605_CR178","doi-asserted-by":"publisher","first-page":"7259","DOI":"10.1038\/s41598-022-11339-w","volume":"12","author":"C Wang","year":"2022","unstructured":"Wang C, Liu H. Factors influencing degradation kinetics of mRNAs and half-lives of microRNAs, circRNAs, lncRNAs in blood in vitro using quantitative PCR. Sci Rep. 2022;12:7259.","journal-title":"Sci Rep"},{"key":"2605_CR179","doi-asserted-by":"publisher","first-page":"742","DOI":"10.3390\/biomedicines11030742","volume":"11","author":"I Paez","year":"2023","unstructured":"Paez I, Prado Y, Loren P, Ubilla CG, Rodr\u00edguez N, Salazar LA. Cholesterol-Related lncRNAs as Response Predictors of Atorvastatin Treatment in Chilean Hypercholesterolemic Patients: A Pilot Study. Biomedicines. 2023;11:742.","journal-title":"Biomedicines"},{"key":"2605_CR180","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2020.103079","volume":"61","author":"LF Reeskamp","year":"2020","unstructured":"Reeskamp LF, Venema A, Pereira JPB, Levin E, Nieuwdorp M, Groen AK, et al. Differential DNA methylation in familial hypercholesterolemia. EBioMedicine. 2020;61: 103079.","journal-title":"EBioMedicine"},{"key":"2605_CR181","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3389\/fcvm.2019.00005","volume":"6","author":"A Sarraju","year":"2019","unstructured":"Sarraju A, Knowles JW. Genetic Testing and Risk Scores: Impact on Familial Hypercholesterolemia. Front Cardiovasc Med. 2019;6:5.","journal-title":"Front Cardiovasc Med"},{"key":"2605_CR182","unstructured":"Warden BA, Fazio S, Shapiro MD. Familial Hypercholesterolemia: Genes and Beyond. In: Feingold KR, Ahmed SF, Anawalt B, Blackman MR, Boyce A, Chrousos G, et al., editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000 [cited 2025 Apr 8]. Available from: http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK343488\/"},{"key":"2605_CR183","doi-asserted-by":"publisher","unstructured":"Gourvest M, Barcia JG, Zhang T, Wang J, Peled D, Newman A, et al. Abstract 1049: Long Noncoding RNA Regulation Of Inflammation In Atherosclerosis. Arterioscler Thromb Vasc Biol [Internet]. 2024 [cited 2025 Mar 5];44. Available from: https:\/\/www.ahajournals.org\/doi\/https:\/\/doi.org\/10.1161\/atvb.44.suppl_1.1049","DOI":"10.1161\/atvb.44.suppl_1.1049"},{"key":"2605_CR184","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s11883-020-00872-6","volume":"22","author":"T Josefs","year":"2020","unstructured":"Josefs T, Boon RA. The Long Non-coding Road to Atherosclerosis. Curr Atheroscler Rep. 2020;22:55.","journal-title":"Curr Atheroscler Rep"},{"key":"2605_CR185","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2022.894800","volume":"10","author":"H Keshavarz Alikhani","year":"2022","unstructured":"Keshavarz Alikhani H, Pourhamzeh M, Seydi H, Shokoohian B, Hossein-khannazer N, Jamshidi-adegani F, et al. Regulatory Non-Coding RNAs in Familial Hypercholesterolemia. Theranostic Applications Front Cell Dev Biol. 2022;10: 894800.","journal-title":"Theranostic Applications Front Cell Dev Biol"},{"key":"2605_CR186","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1007\/s11010-017-2984-2","volume":"431","author":"KK Singh","year":"2017","unstructured":"Singh KK, Matkar PN, Pan Y, Quan A, Gupta V, Teoh H, et al. Endothelial long non-coding RNAs regulated by oxidized LDL. Mol Cell Biochem. 2017;431:139\u201349.","journal-title":"Mol Cell Biochem"},{"key":"2605_CR187","doi-asserted-by":"publisher","first-page":"24","DOI":"10.3389\/fimmu.2020.00024","volume":"11","author":"Y Yan","year":"2020","unstructured":"Yan Y, Song D, Wu J, Wang J. Long Non-Coding RNAs Link Oxidized Low-Density Lipoprotein With the Inflammatory Response of Macrophages in Atherogenesis. Front Immunol. 2020;11:24.","journal-title":"Front Immunol"},{"key":"2605_CR188","doi-asserted-by":"publisher","first-page":"170","DOI":"10.2174\/1389203723666220429083753","volume":"23","author":"D Wang","year":"2022","unstructured":"Wang D, Yeung AWK, Atanasov AG. A Review: Molecular Mechanism of Regulation of ABCA1 Expression. Curr Protein Pept Sci. 2022;23:170\u201391.","journal-title":"Curr Protein Pept Sci"},{"key":"2605_CR189","doi-asserted-by":"publisher","unstructured":"Yu X-H, Tang C-K. ABCA1, ABCG1, and Cholesterol Homeostasis. In: Zheng L, editor. HDL Metab Dis [Internet]. Singapore: Springer Nature Singapore; 2022 [cited 2025 Mar 5]. p. 95\u2013107. Available from: https:\/\/link.springer.com\/https:\/\/doi.org\/10.1007\/978-981-19-1592-5_7","DOI":"10.1007\/978-981-19-1592-5_7"},{"key":"2605_CR190","doi-asserted-by":"crossref","unstructured":"Yvan-Charvet L, Ranalletta M, Wang N, Han S, Terasaka N, Li R, Welch C, Tall AR. Combined deficiency of ABCA1 and ABCG1 promotes foam cell accumulation and accelerates atherosclerosis in mice. J Clin Invest. 2007;117(12):3900\u20138.","DOI":"10.1172\/JCI33372"},{"key":"2605_CR191","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacl.2019.04.031","volume":"13","author":"LR Brunham","year":"2019","unstructured":"Brunham LR, Trinder M, Cermakova L, Francis G, Mancini GB. Impact of Monogenic Familial Hypercholesterolemia and Polygenic Hypercholesterolemia Cardiovascular Disease Risk*. J Clin Lipidol. 2019;13: e14.","journal-title":"J Clin Lipidol"},{"key":"2605_CR192","doi-asserted-by":"publisher","first-page":"S11","DOI":"10.1016\/j.jacl.2015.04.009","volume":"9","author":"SD De Ferranti","year":"2015","unstructured":"De Ferranti SD. Familial hypercholesterolemia in children and adolescents: A clinical perspective. J Clin Lipidol. 2015;9:S11\u20139.","journal-title":"J Clin Lipidol"},{"key":"2605_CR193","doi-asserted-by":"publisher","first-page":"669","DOI":"10.3390\/genes14030669","volume":"14","author":"SE Van Den Bosch","year":"2023","unstructured":"Van Den Bosch SE, Corpeleijn WE, Hutten BA, Wiegman A. How Genetic Variants in Children with Familial Hypercholesterolemia Not Only Guide Detection, but Also Treatment. Genes. 2023;14:669.","journal-title":"Genes"},{"key":"2605_CR194","first-page":"11","volume":"12","author":"OAA Beylerli","year":"2020","unstructured":"Beylerli OAA, Gareev IF, Izmailov A, Lipatov ON. Features of profiling methods for the expression of long non-coding RNAs in tumors. Her North-West State Med Univ Named II Mechnikov. 2020;12:11\u201320.","journal-title":"Her North-West State Med Univ Named II Mechnikov"},{"key":"2605_CR195","first-page":"12","volume":"6","author":"S Uchida","year":"2017","unstructured":"Uchida S. High-Throughput Methods to Detect Long Non-Coding RNAs. High-Throughput. 2017;6:12.","journal-title":"High-Throughput"},{"key":"2605_CR196","doi-asserted-by":"publisher","first-page":"e0291209","DOI":"10.1371\/journal.pone.0291209","volume":"18","author":"WW Wilfinger","year":"2023","unstructured":"Wilfinger WW, Eghbalnia HR, Mackey K, Miller R, Chomczynski P. Whole blood RNA extraction efficiency contributes to variability in RNA sequencing data sets. Saha S, editor. PLOS ONE. 2023;18:e0291209.","journal-title":"PLOS ONE."},{"key":"2605_CR197","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s40364-022-00409-w","volume":"10","author":"L Cab\u00fas","year":"2022","unstructured":"Cab\u00fas L, Lagarde J, Curado J, Lizano E, P\u00e9rez-Boza J. Current challenges and best practices for cell-free long RNA biomarker discovery. Biomark Res. 2022;10:62.","journal-title":"Biomark Res"},{"key":"2605_CR198","doi-asserted-by":"publisher","first-page":"BSR20181610","DOI":"10.1042\/BSR20181610","volume":"38","author":"F Luo","year":"2018","unstructured":"Luo F, Wang T, Zeng L, Zhu S, Cao W, Wu W, et al. Diagnostic potential of circulating LncRNAs in human cardiovascular disease: a meta-analysis. Biosci Rep. 2018;38:BSR20181610.","journal-title":"Biosci Rep."},{"key":"2605_CR199","doi-asserted-by":"publisher","first-page":"1","DOI":"10.21926\/obm.transplant.2402217","volume":"08","author":"N Motazedian","year":"2024","unstructured":"Motazedian N, Mokhtari M, Azarpira N, Falamarzi K, Mohammadi M, Dehghani SM, et al. Circulating lncRNAs HOTTIP and HOTAIR as Potential Biomarkers in Crigler-Najjar Syndrome: A Preliminary Report from Shiraz Liver Transplant Research Center. OBM Transplant. 2024;08:1\u201316.","journal-title":"OBM Transplant"},{"key":"2605_CR200","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s40364-024-00590-0","volume":"12","author":"L P\u00e9rez-Carrillo","year":"2024","unstructured":"P\u00e9rez-Carrillo L, Gim\u00e9nez-Escamilla I, Gonz\u00e1lez-Torrent I, Delgado-Arija M, S\u00e1nchez-L\u00e1zaro I, Garc\u00eda-Manzanares M, et al. Circulating long non-coding RNAs detection after heart transplantation and its accuracy in the diagnosis of acute cardiac rejection. Biomark Res. 2024;12:49.","journal-title":"Biomark Res"},{"key":"2605_CR201","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s13059-016-0873-8","volume":"17","author":"AE Kornienko","year":"2016","unstructured":"Kornienko AE, Dotter CP, Guenzl PM, Gisslinger H, Gisslinger B, Cleary C, et al. Long non-coding RNAs display higher natural expression variation than protein-coding genes in healthy humans. Genome Biol. 2016;17:14.","journal-title":"Genome Biol"},{"key":"2605_CR202","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1016\/j.jacl.2017.03.009","volume":"11","author":"M Mazidi","year":"2017","unstructured":"Mazidi M, Penson P, Gluba-Brzozka A, Rysz J, Banach M. Relationship between long noncoding RNAs and physiological risk factors of cardiovascular disease. J Clin Lipidol. 2017;11:617\u201323.","journal-title":"J Clin Lipidol"},{"key":"2605_CR203","doi-asserted-by":"crossref","unstructured":"Charng M-J. Treatment of Homozygous Familial Hypercholesterolemia: Challenges and Latest Development. In: Huang C, Freter C, editors. Cholest Low Ther Drugs [Internet]. InTech; 2016 [cited 2025 Mar 5]. Available from: http:\/\/www.intechopen.com\/books\/cholesterol-lowering-therapies-and-drugs\/treatment-of-homozygous-familial-hypercholesterolemia-challenges-and-latest-development","DOI":"10.5772\/63949"},{"key":"2605_CR204","doi-asserted-by":"publisher","first-page":"751","DOI":"10.5551\/jat.CR003","volume":"25","author":"M Harada-Shiba","year":"2018","unstructured":"Harada-Shiba M, Arai H, Ishigaki Y, Ishibashi S, Okamura T, Ogura M, et al. Guidelines for Diagnosis and Treatment of Familial Hypercholesterolemia 2017. J Atheroscler Thromb. 2018;25:751\u201370.","journal-title":"J Atheroscler Thromb"},{"key":"2605_CR205","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2020.574474","volume":"11","author":"M Vrablik","year":"2020","unstructured":"Vrablik M, Tich\u00fd L, Freiberger T, Blaha V, Satny M, Hubacek JA. Genetics of Familial Hypercholesterolemia: New Insights. Front Genet. 2020;11: 574474.","journal-title":"Front Genet"},{"key":"2605_CR206","doi-asserted-by":"publisher","first-page":"111614","DOI":"10.1109\/ACCESS.2020.3002588","volume":"8","author":"M Chen","year":"2020","unstructured":"Chen M, Peng Y, Li A, Deng Y, Li Z. A Novel lncRNA-Disease Association Prediction Model Using Laplacian Regularized Least Squares and Space Projection-Federated Method. IEEE Access. 2020;8:111614\u201325.","journal-title":"IEEE Access"},{"key":"2605_CR207","doi-asserted-by":"publisher","first-page":"3801","DOI":"10.1038\/s41598-021-83392-w","volume":"11","author":"M Correia","year":"2021","unstructured":"Correia M, Kagenaar E, Van Schalkwijk DB, Bourbon M, Gama-Carvalho M. Machine learning modelling of blood lipid biomarkers in familial hypercholesterolaemia versus polygenic\/environmental dyslipidaemia. Sci Rep. 2021;11:3801.","journal-title":"Sci Rep"},{"key":"2605_CR208","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1093\/bfgp\/elae010","volume":"23","author":"B Diao","year":"2024","unstructured":"Diao B, Luo J, Guo Y. A comprehensive survey on deep learning-based identification and predicting the interaction mechanism of long non-coding RNAs. Brief Funct Genomics. 2024;23:314\u201324.","journal-title":"Brief Funct Genomics"},{"key":"2605_CR209","doi-asserted-by":"publisher","first-page":"3961","DOI":"10.1021\/acs.jcim.3c01619","volume":"64","author":"P Kamya","year":"2024","unstructured":"Kamya P, Ozerov IV, Pun FW, Tretina K, Fokina T, Chen S, et al. PandaOmics: An AI-Driven Platform for Therapeutic Target and Biomarker Discovery. J Chem Inf Model. 2024;64:3961\u20139.","journal-title":"J Chem Inf Model"},{"key":"2605_CR210","doi-asserted-by":"publisher","first-page":"bbae623","DOI":"10.1093\/bib\/bbae623","volume":"26","author":"Y-Y Li","year":"2024","unstructured":"Li Y-Y, Qian F-C, Zhang G-R, Li X-C, Zhou L-W, Yu Z-M, et al. FunlncModel: integrating multi-omic features from upstream and downstream regulatory networks into a machine learning framework to identify functional lncRNAs. Brief Bioinform. 2024;26:bbae623.","journal-title":"Brief Bioinform."},{"key":"2605_CR211","doi-asserted-by":"publisher","first-page":"5680","DOI":"10.1016\/j.csbj.2022.10.011","volume":"20","author":"Y Luo","year":"2022","unstructured":"Luo Y, Liu L, He Z, Zhang S, Huo P, Wang Z, et al. TREAT: Therapeutic RNAs exploration inspired by artificial intelligence technology. Comput Struct Biotechnol J. 2022;20:5680\u20139.","journal-title":"Comput Struct Biotechnol J"},{"key":"2605_CR212","doi-asserted-by":"publisher","first-page":"1946","DOI":"10.1109\/TCBB.2020.2964221","volume":"18","author":"H Wei","year":"2021","unstructured":"Wei H, Liao Q, Liu B. iLncRNAdis-FB: Identify lncRNA-Disease Associations by Fusing Biological Feature Blocks Through Deep Neural Network. IEEE\/ACM Trans Comput Biol Bioinform. 2021;18:1946\u201357.","journal-title":"IEEE\/ACM Trans Comput Biol Bioinform"},{"key":"2605_CR213","doi-asserted-by":"publisher","first-page":"1388015","DOI":"10.3389\/fgene.2024.1388015","volume":"15","author":"P Xu","year":"2024","unstructured":"Xu P, Li C, Yuan J, Bao Z, Liu W. Predict lncRNA-drug associations based on graph neural network. Front Genet. 2024;15:1388015.","journal-title":"Front Genet"},{"key":"2605_CR214","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s12943-019-1017-z","volume":"18","author":"S Xu","year":"2019","unstructured":"Xu S, Wang P, Zhang J, Wu H, Sui S, Zhang J, et al. Ai-lncRNA EGOT enhancing autophagy sensitizes paclitaxel cytotoxicity via upregulation of ITPR1 expression by RNA-RNA and RNA-protein interactions in human cancer. Mol Cancer. 2019;18:89.","journal-title":"Mol Cancer"},{"key":"2605_CR215","doi-asserted-by":"publisher","first-page":"3569","DOI":"10.1021\/acs.jcim.4c00245","volume":"64","author":"P Xuan","year":"2024","unstructured":"Xuan P, Lu S, Cui H, Wang S, Nakaguchi T, Zhang T. Learning Association Characteristics by Dynamic Hypergraph and Gated Convolution Enhanced Pairwise Attributes for Prediction of Disease-Related lncRNAs. J Chem Inf Model. 2024;64:3569\u201378.","journal-title":"J Chem Inf Model"},{"key":"2605_CR216","doi-asserted-by":"crossref","unstructured":"Zhao H, Shi J, Zhang Y, Xie A, Yu L, Zhang C, Lei J, Xu H, Leng Z, Li T, Huang W. LncTarD: A manually-curated database of experimentally-supported functional lncRNA\u2013target regulations in human diseases. Nucleic acids Res. 2020;48(D1):D118\u201326.","DOI":"10.1093\/nar\/gkz985"},{"key":"2605_CR217","doi-asserted-by":"publisher","DOI":"10.1002\/cso2.1050","volume":"3","author":"X Ai","year":"2023","unstructured":"Ai X, Smith MC, Feltus FA. Generative adversarial networks applied to gene expression analysis: An interdisciplinary perspective. Comput Syst Oncol. 2023;3: e1050.","journal-title":"Comput Syst Oncol"},{"key":"2605_CR218","doi-asserted-by":"publisher","unstructured":"DeGroat W, Abdelhalim H, Peker E, Sheth N, Narayanan R, Zeeshan S, et al. Multimodal AI\/ML for discovering novel biomarkers and predicting disease using multi-omics profiles of patients with cardiovascular diseases [Internet]. Genomics; 2024 [cited 2025 Mar 5]. Available from: http:\/\/biorxiv.org\/lookup\/doi\/https:\/\/doi.org\/10.1101\/2024.08.07.607041","DOI":"10.1101\/2024.08.07.607041"},{"key":"2605_CR219","doi-asserted-by":"publisher","unstructured":"Karimzadeh M, Momen-Roknabadi A, Cavazos TB, Fang Y, Chen N-C, Multhaup M, et al. Deep generative AI models analyzing circulating orphan non-coding RNAs enable accurate detection of early-stage non-small cell lung cancer [Internet]. Oncology; 2024 [cited 2025 Mar 5]. Available from: http:\/\/medrxiv.org\/lookup\/doi\/https:\/\/doi.org\/10.1101\/2024.04.09.24304531","DOI":"10.1101\/2024.04.09.24304531"},{"key":"2605_CR220","doi-asserted-by":"publisher","first-page":"3078","DOI":"10.1038\/s41598-023-30168-z","volume":"13","author":"M Lehtim\u00e4ki","year":"2023","unstructured":"Lehtim\u00e4ki M, Mishra BH, Del-Val C, Lyytik\u00e4inen L-P, K\u00e4h\u00f6nen M, Cloninger CR, et al. Uncovering the complex genetic architecture of human plasma lipidome using machine learning methods. Sci Rep. 2023;13:3078.","journal-title":"Sci Rep"},{"key":"2605_CR221","unstructured":"Ying W, Wang D, Hu X, Qiu J, Park J, Fu Y. Revolutionizing Biomarker Discovery: Leveraging Generative AI for Bio-Knowledge-Embedded Continuous Space Exploration [Internet]. arXiv; 2024 [cited 2025 Mar 5]. Available from: https:\/\/arxiv.org\/abs\/2409.15612"},{"key":"2605_CR222","doi-asserted-by":"crossref","unstructured":"Chhotaray S, Jal S. Identifying Biomarkers for Atherosclerosis via Gene Expression and Biological Networking. Curr Cardiol Rev [Internet]. 2025 [cited 2025 Mar 5];21. Available from: https:\/\/www.eurekaselect.com\/238014\/article","DOI":"10.2174\/011573403X340118241113025519"},{"key":"2605_CR223","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s12920-022-01195-y","volume":"15","author":"SK Banik","year":"2022","unstructured":"Banik SK, Baishya S, Das Talukdar A, Choudhury MD. Network analysis of atherosclerotic genes elucidates druggable targets. BMC Med Genomics. 2022;15:42.","journal-title":"BMC Med Genomics"},{"key":"2605_CR224","doi-asserted-by":"publisher","first-page":"3735","DOI":"10.1016\/j.csbj.2021.06.030","volume":"19","author":"M Picard","year":"2021","unstructured":"Picard M, Scott-Boyer M-P, Bodein A, P\u00e9rin O, Droit A. Integration strategies of multi-omics data for machine learning analysis. Comput Struct Biotechnol J. 2021;19:3735\u201346.","journal-title":"Comput Struct Biotechnol J"},{"key":"2605_CR225","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1093\/bib\/bbx044","volume":"19","author":"R Miotto","year":"2018","unstructured":"Miotto R, Wang F, Wang S, Jiang X, Dudley JT. Deep learning for healthcare: review, opportunities and challenges. Brief Bioinform. 2018;19:1236\u201346.","journal-title":"Brief Bioinform"},{"key":"2605_CR226","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1186\/s13059-024-03410-8","volume":"25","author":"L Chen","year":"2024","unstructured":"Chen L, Guo Z, Deng T, Wu H. scCTS: identifying the cell type-specific marker genes from population-level single-cell RNA-seq. Genome Biol. 2024;25:269.","journal-title":"Genome Biol"},{"key":"2605_CR227","doi-asserted-by":"publisher","unstructured":"Frost HR. Leveraging cell type-specificity for gene set analysis of single cell transcriptomics [Internet]. Bioinformatics; 2024 [cited 2025 Mar 5]. Available from: http:\/\/biorxiv.org\/lookup\/doi\/https:\/\/doi.org\/10.1101\/2024.09.25.615040","DOI":"10.1101\/2024.09.25.615040"},{"key":"2605_CR228","doi-asserted-by":"publisher","first-page":"vbad120","DOI":"10.1093\/bioadv\/vbad120","volume":"3","author":"C Schiebout","year":"2023","unstructured":"Schiebout C, Lust H, Huang Y, Frost HR. Cell type-specific interaction analysis using doublets in scRNA-seq. Ouangraoua A, editor. Bioinforma Adv. 2023;3:vbad120.","journal-title":"Bioinforma Adv."},{"key":"2605_CR229","doi-asserted-by":"publisher","unstructured":"Xu K, Liu Y, Lv C, Luo Y, Shi J, Zou H, et al. LncCE: Landscape of Cellular-Elevated LncRNAs in Single Cells Across Normal and Cancer Tissues [Internet]. Cancer Biology; 2024 [cited 2025 Mar 5]. Available from: http:\/\/biorxiv.org\/lookup\/doi\/https:\/\/doi.org\/10.1101\/2024.05.17.594684","DOI":"10.1101\/2024.05.17.594684"},{"key":"2605_CR230","doi-asserted-by":"publisher","first-page":"173","DOI":"10.3389\/fcvm.2019.00173","volume":"6","author":"F Chaudhry","year":"2019","unstructured":"Chaudhry F, Isherwood J, Bawa T, Patel D, Gurdziel K, Lanfear DE, et al. Single-Cell RNA Sequencing of the Cardiovascular System: New Looks for Old Diseases. Front Cardiovasc Med. 2019;6:173.","journal-title":"Front Cardiovasc Med"},{"key":"2605_CR231","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.gpb.2021.02.006","volume":"19","author":"H Luo","year":"2021","unstructured":"Luo H, Bu D, Shao L, Li Y, Sun L, Wang C, et al. Single-Cell Long Non-Coding RNA Landscape of T Cells in Human Cancer Immunity. Genomics Proteomics Bioinformatics. 2021;19:377\u201393.","journal-title":"Genomics Proteomics Bioinformatics"},{"key":"2605_CR232","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1186\/s12864-024-10488-8","volume":"25","author":"L Yi","year":"2024","unstructured":"Yi L, Li Q, Zhu J, Cheng W, Xie Y, Huang Y, et al. Single-nucleus RNA sequencing and lipidomics reveal characteristics of transcriptional and lipid composition in porcine longissimus dorsi muscle. BMC Genomics. 2024;25:622.","journal-title":"BMC Genomics"},{"key":"2605_CR233","doi-asserted-by":"publisher","first-page":"bbaa325","DOI":"10.1093\/bib\/bbaa325","volume":"22","author":"L-L Zheng","year":"2021","unstructured":"Zheng L-L, Xiong J-H, Zheng W-J, Wang J-H, Huang Z-L, Chen Z-R, et al. ColorCells: a database of expression, classification and functions of lncRNAs in single cells. Brief Bioinform. 2021;22:bbaa325.","journal-title":"Brief Bioinform."},{"key":"2605_CR234","doi-asserted-by":"crossref","unstructured":"Parhofer KG. Mipomersen: evidence-based review of its potential in the treatment of homozygous and severe heterozygous familial hypercholesterolemia. Core evidence. 2012:29\u201338.","DOI":"10.2147\/CE.S25239"},{"key":"2605_CR235","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1007\/s11883-019-0809-3","volume":"21","author":"DJ Blom","year":"2019","unstructured":"Blom DJ, Raal FJ, Santos RD, Marais AD. Lomitapide and Mipomersen\u2014Inhibiting Microsomal Triglyceride Transfer Protein (MTP) and apoB100 Synthesis. Curr Atheroscler Rep. 2019;21:48.","journal-title":"Curr Atheroscler Rep"},{"key":"2605_CR236","doi-asserted-by":"publisher","DOI":"10.3389\/fpls.2020.526455","volume":"11","author":"J Neumeier","year":"2021","unstructured":"Neumeier J, Meister G. siRNA Specificity: RNAi Mechanisms and Strategies to Reduce Off-Target Effects. Front Plant Sci. 2021;11: 526455.","journal-title":"Front Plant Sci"},{"key":"2605_CR237","doi-asserted-by":"publisher","unstructured":"Sarkar S, Gebert LFR, MacRae IJ. Structural basis for gene silencing by siRNAs in humans [Internet]. Molecular Biology; 2024 [cited 2025 Mar 5]. Available from: http:\/\/biorxiv.org\/lookup\/doi\/https:\/\/doi.org\/10.1101\/2024.12.05.627081","DOI":"10.1101\/2024.12.05.627081"},{"key":"2605_CR238","doi-asserted-by":"crossref","unstructured":"Alanazi AM, Sheer NA, Alassaf RA, Abuhemid HA, Algannas TS, Alnayil AM, Alomar AM. PCSK9 inhibitors as a new modality for treating dyslipidemia. Int J Med Dev Ctries. 2024;8(3):1030-.","DOI":"10.24911\/IJMDC.51-1703950354"},{"key":"2605_CR239","doi-asserted-by":"publisher","DOI":"10.1002\/hsr2.70174","volume":"7","author":"BM Jeswani","year":"2024","unstructured":"Jeswani BM, Sharma S, Rathore SS, Nazir A, Bhatheja R, Kapoor K. PCSK9 Inhibitors: The Evolving Future. Health Sci Rep. 2024;7: e70174.","journal-title":"Health Sci Rep"},{"key":"2605_CR240","doi-asserted-by":"publisher","first-page":"3622","DOI":"10.2174\/1381612824666181010144823","volume":"24","author":"AN Tsouka","year":"2019","unstructured":"Tsouka AN, Tellis CC, Tselepis AD. Pharmacology of PCSK9 Inhibitors: Current Status and Future Perspectives. Curr Pharm Des. 2019;24:3622\u201333.","journal-title":"Curr Pharm Des"},{"key":"2605_CR241","doi-asserted-by":"publisher","first-page":"323","DOI":"10.3390\/pharmaceutics15020323","volume":"15","author":"\u0141 Wo\u0142owiec","year":"2023","unstructured":"Wo\u0142owiec \u0141, Osiak J, Wo\u0142owiec A, Wijata A, Grze\u015bk E, Kozakiewicz M, et al. Inclisiran\u2014Safety and Effectiveness of Small Interfering RNA in Inhibition of PCSK-9. Pharmaceutics. 2023;15:323.","journal-title":"Pharmaceutics"},{"key":"2605_CR242","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1007\/s13238-017-0464-9","volume":"9","author":"T-L Cheng","year":"2018","unstructured":"Cheng T-L, Qiu Z. Long non-coding RNA tagging and expression manipulation via CRISPR\/Cas9-mediated targeted insertion. Protein Cell. 2018;9:820\u20135.","journal-title":"Protein Cell"},{"key":"2605_CR243","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1097\/MOL.0000000000000591","volume":"30","author":"M Furgurson","year":"2019","unstructured":"Furgurson M, Lagor WR. CRISPR: a promising tool for lipid physiology and therapeutics. Curr Opin Lipidol. 2019;30:172\u20136.","journal-title":"Curr Opin Lipidol"},{"key":"2605_CR244","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1089\/hum.2018.063","volume":"30","author":"S Zhen","year":"2019","unstructured":"Zhen S, Li X. Application of CRISPR-Cas9 for Long Noncoding RNA Genes in Cancer Research. Hum Gene Ther. 2019;30:3\u20139.","journal-title":"Hum Gene Ther"},{"key":"2605_CR245","doi-asserted-by":"publisher","first-page":"S13","DOI":"10.1016\/j.atherosclerosis.2023.06.720","volume":"379","author":"A Mori","year":"2023","unstructured":"Mori A, Malaquias V, Bonjour K, Afonso T, Ferreira G, De Oliveira V, et al. Functional analyses of LDLR genetic variants found in familial hypercholesterolemic patients, using CRISPR\/Cas9. Atherosclerosis. 2023;379:S13\u20134.","journal-title":"Atherosclerosis"},{"key":"2605_CR246","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1002\/hep4.1110","volume":"1","author":"L Omer","year":"2017","unstructured":"Omer L, Hudson EA, Zheng S, Hoying JB, Shan Y, Boyd NL. CRISPR correction of a homozygous low-density lipoprotein receptor mutation in familial hypercholesterolemia induced pluripotent stem cells. Hepatol Commun. 2017;1:886\u201398.","journal-title":"Hepatol Commun"},{"key":"2605_CR247","doi-asserted-by":"publisher","first-page":"2317","DOI":"10.1016\/j.numecd.2023.08.010","volume":"33","author":"RAK Srivastava","year":"2023","unstructured":"Srivastava RAK. New opportunities in the management and treatment of refractory hypercholesterolemia using in vivo CRISPR-mediated genome\/base editing. Nutr Metab Cardiovasc Dis. 2023;33:2317\u201325.","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"2605_CR248","doi-asserted-by":"publisher","first-page":"2","DOI":"10.3390\/synbio3010002","volume":"3","author":"S Majumder","year":"2025","unstructured":"Majumder S, Sen K, Karanjai R. Artificial Intelligence-Based Target for Personalized Interventions of Atherosclerosis from Gut Microbiota Signature. SynBio. 2025;3:2.","journal-title":"SynBio"},{"key":"2605_CR249","doi-asserted-by":"publisher","unstructured":"Zamora A, Masana L, Civeira F, Ibarretxe D, Fanlo-Maresma M, Vila A, et al. Prognostic Stratification of Familial Hypercholesterolemia Patients Using AI Algorithms: A Gender-Specific Approach [Internet]. Cardiovascular Medicine; 2024 [cited 2025 Mar 5]. Available from: http:\/\/medrxiv.org\/lookup\/doi\/https:\/\/doi.org\/10.1101\/2024.10.11.24315359","DOI":"10.1101\/2024.10.11.24315359"},{"key":"2605_CR250","doi-asserted-by":"publisher","first-page":"11187","DOI":"10.3390\/app142311187","volume":"14","author":"T Kocejko","year":"2024","unstructured":"Kocejko T. A Data-Driven Comparative Analysis of Machine-Learning Models for Familial Hypercholesterolemia Detection. Appl Sci. 2024;14:11187.","journal-title":"Appl Sci"},{"key":"2605_CR251","doi-asserted-by":"publisher","first-page":"1237258","DOI":"10.3389\/fcvm.2023.1237258","volume":"10","author":"R-F Luo","year":"2023","unstructured":"Luo R-F, Wang J-H, Hu L-J, Fu Q-A, Zhang S-Y, Jiang L. Applications of machine learning in familial hypercholesterolemia. Front Cardiovasc Med. 2023;10:1237258.","journal-title":"Front Cardiovasc Med"},{"key":"2605_CR252","doi-asserted-by":"publisher","unstructured":"Ahmed Z. Discovering novel biomarkers and predicting cardiovascular disease using AI\/ML techniques for precision medicine. Circulation [Internet]. 2024 [cited 2025 Mar 5];150. Available from: https:\/\/www.ahajournals.org\/doi\/https:\/\/doi.org\/10.1161\/circ.150.suppl_1.4113047","DOI":"10.1161\/circ.150.suppl_1.4113047"},{"key":"2605_CR253","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/s41746-019-0101-5","volume":"2","author":"JM Banda","year":"2019","unstructured":"Banda JM, Sarraju A, Abbasi F, Parizo J, Pariani M, Ison H, et al. Finding missed cases of familial hypercholesterolemia in health systems using machine learning. Npj Digit Med. 2019;2:23.","journal-title":"Npj Digit Med"},{"key":"2605_CR254","doi-asserted-by":"publisher","first-page":"S107","DOI":"10.1016\/j.acvd.2023.10.199","volume":"117","author":"T Pirbay","year":"2024","unstructured":"Pirbay T, Carreau V, Gu\u00e9rin M, Frisdal E, Lesnik P, Mondelli A, et al. Transcriptomic profile helps to identify high-risk heterozygous familial hypercholesterolemia patients. Arch Cardiovasc Dis. 2024;117:S107\u20138.","journal-title":"Arch Cardiovasc Dis"},{"key":"2605_CR255","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/s41746-019-0148-3","volume":"2","author":"P Shah","year":"2019","unstructured":"Shah P, Kendall F, Khozin S, Goosen R, Hu J, Laramie J, et al. Artificial intelligence and machine learning in clinical development: a translational perspective. Npj Digit Med. 2019;2:69.","journal-title":"Npj Digit Med"}],"container-title":["Lipids in Health and Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-025-02605-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12944-025-02605-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-025-02605-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,21]],"date-time":"2025-05-21T05:02:24Z","timestamp":1747803744000},"score":1,"resource":{"primary":{"URL":"https:\/\/lipidworld.biomedcentral.com\/articles\/10.1186\/s12944-025-02605-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,21]]},"references-count":255,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2605"],"URL":"https:\/\/doi.org\/10.1186\/s12944-025-02605-7","relation":{},"ISSN":["1476-511X"],"issn-type":[{"value":"1476-511X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,21]]},"assertion":[{"value":"11 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable, as this is a review article and does not involve human participants, animals, or clinical trial data.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable, as no individual patient data is included in this manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"182"}}